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For a long time, researchers focused on DNA as the primary macromolecule storing 
genetic information and propagating it from mother to daughter cell, and to the next 
generation via the germline (Allis et al., 2015). Due to this, classical Mendelian 
inheritance focused on the differences found in alleles that arose by mutation of the DNA 
sequence. Non-Mendelian inheritance cannot be explained by allelic transmission. X-
inactivation or genomic imprinting, for example manifest through the expression of only 
one of the two alleles even though they are both present in the same nuclear context (Allis 
et al., 2015). Other patterns of non-Mendelian inheritance include Barbara McClintock’s 
“jumping genes”, now more commonly known as transposable elements. (Goldberg et 
al., 2007). These patterns are established by the packaging of the DNA molecule. DNA 
exists as a complex with histone and non-histone proteins (Harr et al., 2016). Together 
with the DNA they comprise chromatin and distinctive forms of chromatin arise through 
nucleosome arrays carrying covalent and noncovalent modifications. The process of 
establishing these modifications encompasses a plethora of different mechanisms; such 
as post-translational histone modifications (Bannister and Kouzarides, 2011; Tessarz and 
Kouzarides, 2014), the exchange of histone variants, (Buschbeck and Hake, 2017), 
energy-dependent chromatin-remodelling that alters or mobilizes nucleosomes (Clapier 
and Cairns, 2009). In addition, DNA itself can be modified covalently, usually at the 
cytosine residue of CpG dinucleotides (Jones, 2012). All of these mechanisms work 
together and are referred to as epigenetic gene regulation or simply epigenetics.  
Epigenetics gives rise to distinct and dynamic chromatin landscapes, some of them stable 
throughout several cell divisions and important for cell identity (Clapier et al., 2017a; Du 
et al., 2015).  
 
1.2. Chromatin 
Chromatin is composed of repeating nucleosomal units, each of which consists of an 
octamer of histone proteins with 147 base pairs (bp) of DNA wrapped around them 
(Davey et al., 2002). The nucleosome organisation was revealed by biochemical studies 
(Kornberg, 1974) which were later confirmed by crystallography studies (Luger et al., 
1997). Together they revealed that the nucleosome unit is made up of dimer sets of histone 
partners (H2A with H2B) and tetramers (H3 with H4) together forming an octamer 
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(Arents et al., 1991). DNA is organized on the octamer surface, wrapping around it, 
leading to a particle with a defined dyad axis. The crystal structures, however did not 
accurately reflect the histone tail domains, which are crucial for many of the functional 
roles of histones since they carry many post-translational modifications (PTMs). 
Chromatin domains can exist in several distinct functional states and this is determined 
by histone modifications, histone variants, nonhistone proteins, nucleosome remodelling 
factors, non-coding RNAs, among many other determinants (Zhou et al., 2019).                    
 
1.2.1. Euchromatin and heterochromatin 
Historically chromatin has been characterized as euchromatin and heterochromatin. 
Euchromatin encompasses regions of “active” chromatin: coding and regulatory elements 
such as promoters and enhancers. The euchromatic state is generally more “open” which 
means decompacted and pertaining a more nuclease-sensitive configuration. The genes 
and regulatory elements within it are poised for transcription but not necessarily 
transcriptionally active even if many of them are compared to the more repressed 
heterochromatin. Present in euchromatic regions are the housekeeping genes of the cells 
which are ubiquitously active as well as developmentally or stress-regulated genes (Quina 
et al., 2006). Nucleosome remodelling machines, histone modifications and histone 
variants all play a role in regulating the euchromatic landscape and are important for the 
engagement of the transcription machinery (Figure 1.2.1) (Klemm et al., 2019).  
When it comes to heterochromatin, a distinction is usually made between constitutive and 
facultative heterochromatin. Constitutive heterochromatin is highly condensed and 
remains so throughout the cell cycle and throughout development. These condensed 
regions often have structural functions such as centromeres and telomeres but constitutive 
silencing is also important for highly repetitive sequences which need to be tightly 
controlled to protect genome stability (Allis et al., 2015; Grewal and Moazed, 2003). 
Facultative heterochromatin on the other hand, has the “potential” for gene expression. 
Depending on the state of development or the cell type it can be either condensed or 
decondensed (Grewal and Moazed, 2003). Examples of facultative heterochromatin are 
X-inactivation, genomic imprinting and genes that are developmentally regulated, such 





Figure 1.2.1: Characteristics of euchromatin and heterochromatin. 
Euchromatin is characterized by transcription factor binding and remodeling complex recruitment 
associated with active transcription and open chromatin. Activating histone modifications, such 
as H3 acetylation and H3K4 trimethylation, are prevalent as are histone variants associated with 
gene transcription (e.g., H2A.Z), depicted in orange. Heterochromatin is often found in noncoding 
regions, such as on DNA repeats. It is characterized by repressive histone methylation, DNA 
methylation, and further compaction by HP1 (Histone Protein 1) recruitment and other 
mechanisms (adapted from (Allis et al., 2015).    
 
Overall, there are certain features that can define these chromatin states which are present 
to varying degrees. The chromatin state is hardly a binary classification and likely more 
of a spectrum. For the sake of this introduction euchromatin and heterochromatin are 




1.2.2. Higher order chromatin structure 
The chromatin fibre can be visualized microscopically as 11 nm “beads on a string” which 
corresponds to the unfolded configuration of DNA periodically wrapped around 
nucleosomes. Higher order chromatin conformations occur along the entire genome and 
shift during cell fate specification and strongly during stages of the cell cycle (Klemm et 
al., 2019). More compact higher-order chromatin structures of 30 nm arise through the 
incorporation of H1 linker histone (Robinson and Rhodes, 2006) and other associated 
proteins and factors such as HP1 (Histone Protein 1). The organisation into larger looped 
chromatin domains of 300-700 nm possibly occurs through the anchoring of the 
chromatin fibre to the nuclear periphery or other scaffolds via nuclear Lamins (Allis et 
al., 2015; Amendola and van Steensel, 2014). Furthermore, this anchoring is not random 
and it is emerging that apart from structural purposes it also gives rise to meaningful 
functional chromosome territories and is physiologically relevant (Bickmore, 2013; 
Bickmore and van Steensel, 2013). For example, in the clustering of silent 
heterochromatin particularly of pericentric foci. Finally, the most condensed chromatin 
structure occurs during mitosis or meiosis at the metaphase stage and it is essential for 
faithful chromosome segregation. This level of chromatin condensation involves a 
dramatic restructuring of the DNA molecules, that together are roughly 1.8m long, into 
discrete chromosomes of 1.5 µm in diameter (Allis et al., 2015; Hirano, 2012; Nasmyth 
and Haering, 2009). Another form of highly condensed chromatin is the pericentric and 
telomeric region which are very specialized chromosomal domains with important 
structural and functional roles.  
Chromatin is very different in each cell type; a neuron has different gene regulation 
requirements than a leukocyte after all. This thesis will investigate chromatin remodelling 
in the unique “open” environment of embryonic stem cells. 
 
1.2.3. Chromatin landscapes in embryonic stem cells 
Embryonic stem cells are a synthetic cell line that is cultured in vitro and is derived from 
the inner cell mass (ICM) of the blastocyst. The development of the zygote showcases a 
gradual loss of totipotency in its cells. Over time the mammalian embryo gives rise to the 
blastocyst, and at this point the cells have acquired different characteristics; the structure 
of the blastocyst consists of a layer of outer cells called the trophectoderm cells which 
will become the placenta. The cells of the ICM of the blastocyst are pluripotent, as in they 
18 
 
will give rise to the foetus and ultimately to the entire new organism (Hackett and Surani, 
2014). Therefore, they contain the potential to evolve into any of the ~200 specialized 
somatic cells. They are the pluripotent stem cells and they differ from somatic and 
differentiated cells in their epigenetic landscape. As development proceeds their potency 
becomes more restricted and the epigenetic marks more rigid. These pluripotent cells of 
the ICM are referred to as ES cells when they are removed from the embryo and cultured 
in vitro.  
To what extent however, are epigenetic mechanisms required to maintain cells in an 
undifferentiated state? There are clear epigenomic differences between the differentiated 
state and the undifferentiated one such as a hyperdynamic plasticity of chromatin in 
pluripotency (Meshorer and Misteli, 2006). Another interlinked aspect is the pluripotency 
network of proteins. Pluripotency factors Octamer-Binding Transcription Factor 4 (Oct4), 
Nanog, SRY-Box Transcription Factor 2 (Sox2) are among the important factors to 
maintain pluripotency and they regulate many other genes involved in ES cell 
maintenance (Boyer et al., 2005; Loh et al., 2006). The differentiation of ES cells is 
defined by the reduced expression of these factors and the acquisition of other markers of 
somatic cells, such as a changed morphology. Epigenetic mechanisms are important for 
the transcriptional repression of several elements that still require silencing in the less 
restricted context of pluripotency due to otherwise detrimental effects on genome stability 
or the maintenance of pluripotency. Among these are pluripotency factors, heterogenous 
repetitive regions and transposable elements (Hainer et al., 2019). The repression of 
transposable elements in ES cells is central to this thesis and is discussed in detail in the 
chapter on endogenous retroviral elements, after the introduction of important factors and 
modifications in chromatin regulation.   
 
1.3. Features of chromatin states 
The chromatin substrate is modified by a multitude of factors and modifications which 
affect its regulation, architecture and access to the DNA. This thesis will introduce histone 
modifications, histone variants, ATP-dependent chromatin remodellers and DNA 
methylation, and then discuss the role they play in genomic imprinting, X-inactivation, 




1.3.1. Histone modifications 
Histone proteins are very conserved in their amino acid sequence from yeast to humans. 
The core nucleosome consists of several histone proteins which are made up of a globular 
domain and a highly flexible and unstructured “histone tail”. These histone tails are 
subject to extensive post-translational-modifications (PTMs), particularly of H3 and H4, 
giving rise to further chromatin variability and distinct functional domains. Since the first 
studies by Allfrey et al. (1964) and Paik and Kim (1971) that identified acetylation and 
methylation of core histones, many further histone modifications have been discovered 
including phosphorylation, sumoylation, ubiquitination, biotinylation, ADP-ribosylation, 
crotonylation, proline isomerization, among others (Allis et al., 2015). 
How are histone modifications established and erased? These processes are carried out 
by a plethora of chromatin-associated enzymatic systems. The enzymes with roles in these 
systems often reside within large multisubunit protein complexes that catalyse the 
incorporation and removal of covalent modifications on their targets. They are generally 
highly target- and cell-type specific (Bannister and Kouzarides, 2011). The major 
enzymes in these group are histone acetyltransferases (HATs), their counterpart the 
histone deacetylases (HDACs), histone kinases, that phosphorylate serine, threonine and 
lysine residues, the phosphatases, that in turn remove these groups, the histone lysine 
methyltransferases, and protein arginine methyltransferases (Bannister and Kouzarides, 
2011; Kouzarides, 2007). In the context of this study the focus will be on histone lysine 
methyltransferases and their action is explored in more detail in the chapter dealing with 
the control of endogenous retroviral elements. The enzymes that counteract the 
methyltransferases are the histone demethylases and arginine deaminases (Bannister and 
Kouzarides, 2011; Kouzarides, 2007).  
Histone modifications habitually affect chromatin structure. For example; histone tail 
acetylation has traditionally been linked to active chromatin domains whereas 
methylation designates both repressed and transcribed areas. Histone modifications work 
in concert with many other epigenetic factors, which they can often provide a binding 
platform for. Examples include; transcription factors, histone chaperones, chromatin 
remodellers, and DNA or histone modifying enzymes (Allis and Jenuwein, 2016; 
Kouzarides, 2007). The misregulation of histone modifications can have severe effects 
and has been implicated in developmental defects and the pathogenesis of cancer, 
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highlighting the biological importance of the regulation of histone modifications (Hyun 
et al., 2017; Wang and Allis, 2009) 
The following study has a particular focus on histone methylation. Methylation can occur 
on lysine or arginine residues of histone tails and the first lysine histone methyltransferase 
discovered was Suppressor of Variegation 3-9 Homolog 1 (SuV39H1). It contains a 
catalytic SET (Su(var)3-9, Enhancer of Zeste, and Trithorax) domain (Rea et al., 2000). 
Until the first demethylase was discovered histone lysine methylation was expected to 
have a slow turnover. The discovery of the H3K4 demethylase LSD1 and later JmjC (Shi 
et al., 2004; Tsukada et al., 2006) demonstrated that these residues can be actively 
removed in the cell.  
There are three distinct lysine methylation states, mono-, di- and trimethylation (me1, 
me2, and me3). None of them result in changes of the electric charge of the amino acid 
side-chain, which suggests that they play a role in chromatin dynamics by attracting other 
effector molecules that contain methyl-lysine binding motifs, such as a PHD (plant 
homeodomain), chromo or tudor domain (Black et al., 2012). These motifs are very 
specific since the location of the lysine and its methylation state, results in vastly different 
outputs, and can lead to activation or repression. Histone lysine methylation on H3K4 is 
generally associated with activation and is found on active promoters. H3K36 is also 
associated with activation and found on actively transcribed gene bodies (Black et al., 
2012). Marks associated with repression are H3K27, H3K9, and H4K20 methylation. 
H3K27me3, for example, is a hallmark of transcriptional repression. It is deposited by the 
histone methyltransferase Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit 
(EZH2) contained within the polycomb complex PRC2 (Cao et al., 2002; Hyun et al., 
2017; Muller et al., 2002; Pirrotta, 1998). Two specific histone lysine methylation marks 
will become important during this study: H4K20me3 and particularly H3K9me3. 
 
H3K9 methylation 
H3K9 methylation is a conserved modification linked to silencing and heterochromatin 
(Barski et al., 2007). Most notably it is found in the constitutive heterochromatin of the 
telomeres and centromeres and it is crucial for the repression of many repetitive DNA 
sequences. Moreover, it is known for its role in chromosomal architecture and is required 
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for the correct segregation of the chromosomes (Peters et al., 2001; Sarraf and Stancheva, 
2004).  
In mammalian cells the histone methyltransferases SuV39h1, SuV39h2, SET Domain 
Bifurcated Histone Lysine Methyltransferase 1 (SETDB1), and G9a are responsible for 
H3K9 methylation, and they possess vastly different activities and targets. SuV39h1/h2 
catalyse H3K9 di-, and trimethylation in constitutive heterochromatin including on 
pericentric regions (Collins et al., 2005; Lachner et al., 2001; Rea et al., 2000; Rice et al., 
2003). The histone methyltransferase G9a consists of a heterodimer of G9a and GLP 
(G9a-like Protein), and it plays a role in euchromatic gene repression via H3K9me1 and 
H3K9me2 (Tachibana et al., 2002). SETDB1 catalyses H3K9 monomethylation on 
pericentric regions where it also provides a substrate for SuV39h1/h2 to produce 
H3K9me3 (Loyola et al., 2009). On retroviral elements SETDB1 is required for 
H3K9me3 together with several necessary co-factors, and many endogenous retroviral 
elements (ERVs) are upregulated upon the depletion of SETDB1 concurrent with the loss 
of H3K9me3 (Bulut-Karslioglu et al., 2014; Karimi et al., 2011; Liu et al., 2014; Matsui 
et al., 2010).  
There are many examples of crosstalk between H3K9 methylation and DNA methylation. 
SuV39h1/h2 interact with the de novo DNA methyltransferases-3a/b (DNMT3a/b) (Fuks 
et al., 2003; Lehnertz et al., 2003), as does G9a-GLP. This illustrates the link of the two 
mechanisms in the establishment of facultative heterochromatin (Epsztejn-Litman et al., 
2008; Feldman et al., 2006). Additionally, components of the DNA methylation 
machinery such as G9a, and the maintenance DNA methyltransferase-1 (DNMT1) have 
been found to co-localise at the replication fork with a conserved replication protein called 
Proliferating Cell Nuclear Antigen (PCNA) (Rothbart et al., 2012), placing H3K9 
methylation conjointly with the maintenance of DNA methylation during DNA 
replication. This is achieved by the protein Ubiquitin Like With PHD And Ring Finger 
Domains 1 (UHRF1/NP95), which brings DNMT1 to the replication fork by interacting 
with methylated H3K9 and hemimethylated CpGs, bridging H3K9 methylation and DNA 
methylation (Hyun et al., 2017; Rothbart et al., 2012).  
H3K9 methylation also plays an important role in the establishment of pericentric 
heterochromatin (Allis et al., 2015). The histone methyltransferases SETDB1 and 
SuV39h1/h2 are recruited to pericentric heterochromatin and catalyse H3K9 methylation 
(Dodge et al., 2004; Loyola et al., 2009; Rea et al., 2000). HP1 then binds H3K9me3 
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through its chromodomains forming multimers that in turn can interact with SuV39h1/h2. 
HP1 further contributes by recruiting other silencing factors and histone deacetylases 
HDAC1/2 (Hall et al., 2002; Lechner et al., 2005; Yamada et al., 2005). 
 
H4K20 trimethylation 
The methyltransferases that catalyse H4K20me3 are restricted to specific methylation 
states (Hyun et al., 2017). One example is the enzyme SET Domain-Containing Protein 
8 (SET8) which is in charge of monomethylation (Fang et al., 2002; Nishioka et al., 2002). 
H4K20me1 is further modified to me2 and me3 by Suppressor Of Variegation 4-20 
Homolog 1 (Suv4-20H1) and Suppressor Of Variegation 4-20 Homolog 2 (Suv4-20H2), 
often together with other factors (Schotta et al., 2004; Schotta et al., 2008; Yang et al., 
2008). Additionally, H4K20 methylation can be regulated by a histone trans-tail 
mechanism where the C-terminal region of Suv4-20H2 interacts with HP1 which in turn 
recognizes H3K9 methylation (Schotta et al., 2004). Hence, the deletion of HP1 or a 
reduction of H3K9 methylation results in decreased heterochromatin targeting of Suv4-
20H2 and in a decrease of H4K20 methylation (Schotta et al., 2004; Yang et al., 2008).  
 
1.3.2. Histone variants 
Histone proteins are very conserved, but some evolved into specialized variants of the 
core histones to allow for another mechanism to introduce variation into the epigenome. 
This in turn results in different possible chromatin structures and nucleosomal dynamics. 
All core histone except H4 have evolved histone variants (Maze et al., 2014). 
For example, the core histone H3 possesses several histone variants. H3.1 and H3.2 are 
considered the “canonical” variants. They are deposited during DNA replication in the S-
phase of the cell by the CAF1 complex and are therefore replication-dependent. Less 
widespread variants of H3 are H3.3 and the centromere-specific isoform 
Centromere Protein A (CENP-A) (Buschbeck and Hake, 2017). H3.3 differs from the 
canonical versions only by a few amino acids but its distribution in the genome and 
functional studies reveal that these differences matter greatly. The canonical H3.1 and 
H3.2 are exchanged for H3.3 at transcriptionally active genes in a transcription-coupled 
manner, replication-independent (Ahmad and Henikoff, 2002). This incorporation into 
active chromatin is performed by the histone regulator A (HIRA) complex. Interestingly, 
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H3.3 is also enriched at repressed chromatin regions, such as telomeric, pericentric and 
repetitive regions. Incorporation into these regions is however, performed by a different 
chaperone complex, the Death Domain Associated Protein/Alpha Thalassemia/Mental 
Retardation Syndrome X-Linked (DAXX-ATRX) complex (Buschbeck and Hake, 2017; 
Goldberg et al., 2010). Hence, even a single histone variant can exhibit very different 
genomic localization and biological function. 
 
1.3.3. ATP-dependent chromatin remodellers 
Remodellers are enzymes that use the energy generated by the hydrolysis of ATP to 
perform a series of processes on chromatin. They can move, destabilize, eject, or 
restructure nucleosomes thereby regulating the accessibility of the DNA polymer. By 
doing this they can transiently expose individual sequences to interacting proteins (Figure 
1.3.1). Often these are regulatory DNA elements (enhancers, promoters, replication 
origins) which in turn are important for a plethora of processes, such as gene transcription, 
DNA replication, DNA repair, and DNA recombination. During replication the DNA 
polymerase must have unhindered access to the DNA and after replication, nucleosomes 
must be deposited once more and spaced properly genome-wide, while still maintaining 
cell identity (Clapier and Cairns, 2009; Durand-Dubief et al., 2012; Muller and Leutz, 
2001). When nucleosomes are tightly packaged and the DNA is wrapped around the 
nucleosome surface, regulatory factors and transcription factors might not be able to bind 
important cis regulatory elements (Figure 1.3.1). In addition, during transcription the 
RNA polymerase must not be impeded by nucleosomes (Clapier and Cairns, 2009). For 
DNA repair it is necessary that all base pairs are exposed to the repair machinery, and for 
DNA recombination it is necessary that long sequences are exposed in a synchronized 
manner for recombination to occur. Remodellers playing a role in this variety of processes 
does not mean they are solely there to enable them. Many remodellers have important 
roles in packaging chromatin more tightly, promoting a dense packaging of histones, in 
order to hinder the access of transcription factors or delay replication (Clapier and Cairns, 




Figure 1.3.1: Processes of ATP-dependent chromatin remodelling.  
The energy generated by remodellers from the hydrolysis of ATP to ADP is used to produce 
changes in chromatin compaction and DNA accessibility. This is achieved in a variety of 
functions; nucleosome deposition and spacing, eviction and nucleosome sliding, and the exchange 
of histone variants.   
 
The role of remodellers in activation and repression of transcription affects the cell cycle 
progression (Muchardt and Yaniv, 2001), cell differentiation (Muller and Leutz, 2001), 
and therefore the development of multicellular organisms. Mutations or the deletion of 
many remodellers often has a severe effect on development. For example, homozygous 
null mutation of Imitation SWitch-1 (ISW1) in flies is lethal as a result of impaired cell 
viability (Deuring et al., 2000).  Remodellers generally have a binding affinity for the 
nucleosome, apart from DNA-binding potential, they often have domains that recognize 
histone modifications, they possess a DNA-dependent ATPase domain that serves as a 
DNA-translocator, other domains or proteins that regulate the ATPase domain, and 
domains or proteins that regulate the interaction with other factors, such as transcription 
factors. They can be grouped into four different families according to sequence features 
outside of their ATPase domain and they often possess unique associated subunits 
depending on their specialization (Flaus et al., 2006). Altogether, this allows for a striking 
diversification of their functions, an example of which is the Nucleosome Remodeling 
Deacetylase (NuRD)-complex. NuRD contains several other subunits in addition to the 
ATPase Mi-2, such as a module consisting of the histone deacetylases HDAC1/2 and the 
H4 interacting proteins Retinoblastoma protein associated proteins-46/48 (RbAP46/48) 
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are also present (Kikyo et al., 2000; Knoepfler and Eisenman, 1999), so this complex 
combines ATP-dependent remodelling with the ability to covalently modify histone tails 
(deacetylation) on chromatin. Additionally, the methyl-cytosine binding protein MBD2 
(Wade et al., 1999; Zhang et al., 1999) can associate with NuRD to form the MeCP1 
complex. By this NuRD is targeted, remodels and deacetylates nucleosomes containing 
methylated DNA (Feng and Zhang, 2001). In addition, the two chromodomains that 
reside in Mi-2 appear to recognize DNA rather than methylated histone tails (Brehm et 
al., 2004). Thus, the remodeller integrates many processes of chromatin regulation.  
For a long time, it was thought that remodellers scan along the chromatin fibre not unlike 
the repair machinery. This was because many remodellers themselves have no DNA 
binding capacity. It soon emerged, however, that this function is often provided by other 
proteins they interact with that do possess sequence-specific DNA-binding (Becker and 
Horz, 2002). For example, the corepressor KAP1 uses a bromodomain-PHD domain to 
target the NuRD complex to promoters for repression (Becker and Horz, 2002). 
 
1.3.4. DNA methylation 
DNA methylation is one of the main epigenetic mechanisms of repression. It involves 
converting cytosine residues by addition of a methyl group to 5’methylcytosine (5mC) 
on the DNA and this modification can be transmitted through cell division (Allis et al., 
2015; Greenberg and Bourc'his, 2019; Smith and Meissner, 2013). It is present in most 
multicellular organisms, mainly at CpG dinucleotides or CpG “islands”. DNA 
methylation is enriched at noncoding regions, such as centromeric heterochromatin, and 
on interspersed repeats, such as retrotransposons. On the other hand, it is low in 5’ 
regulatory regions of genes (Bird, 1986) but is present in most exons and introns at high 
levels.  
The effectors of DNA methylation are the DNA methyltransferases. They are often 
grouped into DNMTs for de novo and for maintenance DNA methylation. Maintenance 
methylation is performed by DNMT1 following replication (Song et al., 2011). DNMT1 
is bound to unmethylated CpGs at replication via its CXXC-motif. When the enzyme 
encounters hemimethylation it is allosterically activated and adds methyl groups on the 
unmethylated sister strand. DNMT1 interacts with UHRF1/NP95, and this interaction 
enhances its stability on chromatin. Furthermore, NP95 interacts with H3K9me3 histone 
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modifications which gives rise to a functional connection between DNA methylation and 
repressive histone methylation (Du et al., 2015).  
De novo DNA methylation is performed by the de novo DNA methylases DNMT3A and 
DNMT3B, which associate with the catalytically inactive DNMT3L. There is interplay 
between DNA methylation and histone modifications (Allis et al., 2015). For example, 
the active histone mark H3K4me3 inhibits DNMTL3 binding protecting CpG islands 
from DNA methylation (Cedar and Bergman, 2009). DNA methylation plays a variety of 
roles in epigenetic repression. In genomic imprinting, for example, the cause of allelic 
difference is DNA methylation on the maternal or paternal allele, including on the 
inactive X. It is also found in repetitive regions in the mammalian genome where DNA 
methylation is important to ensure genome stability, since many repeats have mutagenic 
potential if activated, which results in chromosomal abnormalities and is often seen in 
cancer progression. 
 
1.3.5. Genomic imprinting  
Mammals are diploid which means they have matched sets of two chromosomes in their 
cells, one from each parent. Therefore, they have two copies of every gene. Genomic 
imprinting is the phenomenon wherein one of these copies is not expressed. In humans 
only a few hundred of the approximately 25,000 genes in our genome show imprinting 
and this variation in expression is a consequence of parental inheritance (Reik and Walter, 
2001). Genes that are imprinted, largely code for factors regulating embryonic and 
neonatal growth. Genomic imprinting is a cis-acting mechanism of gene repression and 
the imprints are acquired during gamete formation; thus, no type of recognition system is 
required to differentiate between the two alleles. Imprinted genes are usually arranged in 
clusters (Barlow and Bartolomei, 2014; Reik and Walter, 2001). In the mouse there are 
~150 known imprinted genes on 17 chromosomes and roughly 80% of them are clustered 
into 16 genomic regions that contain at least two imprinted genes (Barlow and 
Bartolomei, 2014). Furthermore, imprints can act on multiple genes at once and these are 
mainly protein-coding genes, albeit lncRNAs are also represented in the clustered regions 
of imprints. These clusters are controlled by imprinting control regions (ICRs), and these 
regions are gametic differentially methylated, which means that they are established in 
one gamete and maintained on only one parental chromosome in the diploid cells of the 
embryo (Barlow and Bartolomei, 2014). These elements control the expression of the 
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cluster and DNA methylation is the initial gametic imprint that establishes the cluster and 
the whole imprinted region. Once formed in the gametes, the imprints need to be 
maintained and additionally, possess the capacity to escape genome-wide reprogramming 
after fertilization, which includes DNA demethylation in the preimplantation embryo 
(Barlow and Bartolomei, 2014; Reik and Walter, 2001). 
 
1.3.6. X-inactivation  
Non-coding RNAs (ncRNAs) play a crucial role in triggering epigenetic changes in 
chromatin dynamics. One example is X-inactivation in mammalian females. It involves 
the directed chromosome-wide silencing of one X chromosome during the development 
in female cells. It occurs to achieve dosage compensation between the sex chromosomes 
and the autosomes, so genes on the autosomes can function using the same dosage as they 
would in male cells. The inactive X can be seen localized to the nuclear periphery of the 
cell and is referred to as a Barr body (Allis et al., 2015).  
In mice the large ncRNA Xist (~17 kb) is the primary trigger (Brockdorff et al., 1992; 
Brown et al., 1991) of the chromosome-wide repression on the X chromosome. Its 
antisense transcript Tsix is also involved in the initiation, it is however expressed only 
before the onset of X-inactivation and it appears that its role is not through RNAi-
dependent mechanisms (Allis et al., 2015; Lee and Lu, 1999). The X-inactivation centre 
(XIC) and DNA docking sites are sites where the Xist RNA associates and functions as a 
scaffolding molecule decorating the entire inactive X chromosome in cis (Allis et al., 
2015). The DNA docking sites are thought to be specialized repetitive DNA elements that 
are enriched on the X chromosome (Chow et al., 2010). The XIC region contains Xist and 
Tsix, in addition to several other ncRNAs that play both activating and repressive roles in 
X-inactivation. One example is the ncRNA activator Rnf12 (Jonkers et al., 2009), another 
example is the Jpx ncRNA (Tian et al., 2010). 
Chromatin modifications, PcG complex binding, subsequent incorporation of histone 
variant macroH2A and extensive DNA methylation all contribute to the formation of 
facultative heterochromatin along the entire inactive X (Allis et al., 2015). Once the 
repressive chromatin environment is established the Xist ncRNA is no longer required 




1.4. Endogenous retroviral elements 
Endogenous retroviral elements (ERVs) are one of the most fascinating types of 
transposable elements (TEs) that can shape the genome of the host they invade. TEs are 
DNA sequences that can change their position within the genome and due to their long 
evolutionary history in genomes and the fact that they continue to diversify, they come in 
a large variety of forms and shapes (Bourque et al., 2018). These mobile elements were 
first discovered in maize by Barbara McClintock in the 1950s. She had the remarkable 
foresight to recognize them as “controlling elements” and it was one of the first 
discoveries of non-mendelian inheritance (Schlesinger and Goff, 2015).  
There are two major classes of TEs based on their mode of transposition, DNA 
transposons and retrotransposons, and each of these classes can be further divided into 
subclasses based on the mechanism of chromosomal integration (Figure 1.4.1) (Bourque 
et al., 2018). DNA transposons use a “cut-and-paste” mechanism of genomic integration 
via a DNA intermediate whereas retrotransposons employ a mechanism of “copy-and-
paste” where an RNA intermediate is reverse transcribed into cDNA and integrated 
elsewhere in the genome (Boeke et al., 1985). Retrotransposons are then further divided 
into long terminal repeat (LTR) containing elements and non-LTR elements (Figure 
1.4.1). TE subclasses are further divided into groups which can be found across different 
organisms. These elements share a common genetic organisation and a monophyletic 
origin (Jern et al., 2005; Malik and Eickbush, 2001).  Finally, they are grouped into 
families of closely related elements which are all descendants of a single ancestral unit 
and share a consensus sequence which defines their characterisation and is representative 
of the entire family (Jurka and Smith, 1988; Smit, 1999). Focusing in more detail on 
specific elements, there are LINE (long interspersed elements) and SINE (short 
interspersed elements) repeats within the non-LTR containing retrotransposons and they 
make up around 35% of human and mice genomes (Figure 1.4.1). There are roughly 4800 
full-length LINE copies in the mouse and 3000 are predicted to be active (Grabundzija et 
al., 2016). SINEs arose from accidental retrotransposition of Pol III transcripts and they 
rely on the machinery of LINEs for trans-acting transposition. In humans the Alu family 
is an active SINE family. In mouse several different families exist that are derived from 
tRNA and 7SL genes (Stocking and Kozak, 2008).  
LTR-containing retrotransposons include endogenous retroviral elements (ERVs) which 
make up almost 10% of human and mouse genomes (Figure 1.4.1). They are however 
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much more active in the mouse where 10% of spontaneous mutations in inbred mice are 
due to the action of ERVs (Rowe and Trono, 2011). ERVs strongly resemble the 
exogenous retrovirus they evolved from. They generally encode a gag (group specific 
antigen) a pro (protease) and a pol (polymerase). Some few ERVs still encode envelope 
proteins (env) (Figure 1.4.1). ERVs have often accumulated several mutations and/or 
become truncated since their first integration into the hosts’ genome.  
 
 
Figure 1.4.1: Classification of transposable elements in the mammalian genome.  
(a) Classification of transposable elements depicting the major classes of elements endogenous to 
mammalian genomes. (b) Depiction of the main structural differences in transposable elements 
(DNA transposons; ERVs, endogenous retrovirus; LINEs, long interspersed elements; SINEs, 
short interspersed elements) in mammalian genomes. IR, inverted 
repeat; UTR, untranslated region; ORF, open reading frame; EN, endonuclease; RT, reverse 
transcriptase; LTR, long terminal repeat; ERV, endogenous retrovirus. This illustration is 




ERVs are generally grouped into classes according to their similarity to modern 
exogenous retroviruses, which have been classified into seven genera: alpha-, beta-, 
gamma-, delta, and epsilonretrovirus, lentivirus, and spumavirus. Using this system ERVs 
clustering with gamma- and epsilonretrovirus are termed class I, those that cluster with 
lentivirus, alpha-, beta- and deltaviruses are termed class II, and those that cluster with 
spumaviruses are termed class III. Intermediates between the classes have been identified 
suggesting an evolutionary continuum (Stocking and Kozak, 2008). Class III ERVs make 
up 5.4% of the mouse genome (Mouse Genome Sequencing et al., 2002). They are likely 
the most ancient ERVs, predating the human-mouse speciation (Benit et al., 1999; Mouse 
Genome Sequencing et al., 2002). Two types of transposon elements constitute the class 
III ERVs: murine ERV-L elements (MuERVL or MERVL) and the non-autonomous 
MaLRs. Despite its age this class has maintained some MuERVL elements in an active 
state in the mouse (Benit et al., 1999; Costas, 2003). Class II ERVs make up 3.2% of the 
mouse genome, which is a 10-fold higher proportion than in humans (Mouse Genome 
Sequencing et al., 2002). A large family within this class are MusD elements, with their 
deleted variants denoted ETn (early transposon (Brulet et al., 1983; Mager and Freeman, 
2000). MusD elements lack an env gene. They are flanked by LTRs but contain mainly 
non-retroviral, non-coding sequences of unknown origin. Another well-characterised 
clade within the class II ERVs are intracisternal A-type particles (IAPs), which are present 
in mice at approximately 1000 copies per cell (Kuff and Lueders, 1988). Some of them 
still encode an env gene (Reuss, 1992; Ribet et al., 2008). They span several kb in length, 
generally up to 10kb, and display a number of subclasses and are actively transposing in 
the mouse. Intronic insertions are predominant for IAP elements and are denoted with the 
-int suffix (IAP-int, IAPEz-int). Solitary truncated IAP-LTRs are similarly common. The 
class I ERVs in the mouse include VL30 (virus-like 30) elements, which are 5-6 kb long 
DNA sequences which contain no open reading frames and no evidence for an env 
retroviral gene (Markopoulos et al., 2016). Thus, it is likely that they are non-autonomous 
in their retrotransposition.  
 
1.4.1. Control of ERVs 
ERVs are motors of evolution but at the same time they are threats to the stability of the 
genome. (Rowe and Trono, 2011). If ERVs are left unchecked within the genome they 
can cause harm by insertional mutagenesis and by erroneous non-allelic homologous 
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recombination if many copies of the element are present in the genome. This in turn leads 
to genome instability (Feschotte and Gilbert, 2012). Therefore, they need to be controlled 
tightly. The cell has many available pathways to silence ERVs in order to prevent harm. 
Among them DNA methylation, histone modifications and RNA-based mechanisms 
(Groh and Schotta, 2017), and these are all employed at different stages of development 
and in varying combinations in distinct cell types. For example, DNA methylation is the 
common mechanism in differentiated cells (Hutnick et al., 2010). In the dynamic 
chromatin environment of the developing embryo, it is important that repression 
withstands the demethylation wave in the cleavage embryo and ES cells are famously 
hypomethylated. In these contexts, histone modifications, particularly H3K9 methylation 
become very important for the repression of ERVS (Bulut-Karslioglu et al., 2014; Karimi 
et al., 2011; Rowe et al., 2010).  
Mammalian genomes contain hundreds of ERVs and the transcriptional regulator KRAB-
associated protein-1 (KAP1/TRIM28) is crucial for the repression of many different ERV 
types in both pluripotent and somatic cells (Ecco et al., 2016; Rowe et al., 2010; Tie et 
al., 2018). KAP1 is a major transcriptional regulator which also has non-transcriptional 
functions. KAP1 is ubiquitously expressed throughout development (Cammas et al., 
2000) and it is a critical regulator of normal development and differentiation: mice 
deficient in KAP1 die before gastrulation (Cammas et al., 2000). KAP1 is also involved 
in maintaining pluripotency (Hu et al., 2009) and is required for the terminal 
differentiation of mES cells (Cammas et al., 2004; Cammas et al., 2002). The conditional 
genetic deletion of KAP1 in mES cells leads to overexpression of class I and II ERVs and 
class III to a lesser extent. Particularly IAP class II ERVs, are deregulated and the 
repressive histone marks H3K9me3 and H4K20me3 are lost (Rowe et al., 2010; Rowe et 
al., 2013). Additionally, IAPs are also derepressed in the epiblast embryo upon the loss 
of KAP1 (Rowe et al., 2010).  
The best studied example of KAP1 repression is the Moloney murine leukaemia virus 
(MuLV) that has become endogenous in mice. In ES cells this viral sequence is silenced 
and this is dependent on the conserved sequence of the primer binding site (PBS) (Barklis 
et al., 1986). This is an 18-nucleotide sequence which is complementary to the 3’-end of 
the proline tRNA, which is the tRNA primer employed my MuLV for reverse 
transcription (Harada et al., 1979; Petersen et al., 1991). The PBS of MuLV and VL30, 
and many other class I ERVs, are bound by a specific Kruppel-associated box zinc finger 
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protein (KRAB-ZFP), the ZFP809 (Figure 1.4.2) (Wolf and Goff, 2009; Wolf et al., 
2015). These are sequence-specific transcription factors that have C-terminal arrays of 
C2H2 (Cys2-His2) zinc fingers that bind specific DNA sequences (Urrutia, 2003). There 
are more than 400 human KRAB-ZFP genes that encode for more than 700 different 
proteins (Huntley et al., 2006) postulated to regulate all kind of different processes from 
embryonic development to cancer progression (Urrutia, 2003).  
 
Figure 1.4.2: Recruitment of the KAP1-silencing complex. 
ZFPs bind to the PBS of ERVs and recruit KAP1 which serves as a binding platform for repressive 
factors such as the histone methyltransferase SETDB1, DNA methyltransferases (DNMTs), 
histone deacetylases (HDACs) and HP1. SETDB1 and the DNMTs gives rise to H3K9me3 and 
DNA methylation whereas the HDACs remove histone acetylation. HP1 recruitment results in 
further compaction of chromatin resulting in ERV repression. 
 
KRAB-ZFPs differ significantly between species and many are primate-specific and are 
thought to be involved in the regulation of the immune and nervous systems (Nowick et 
al., 2010). A key question is how KAP1 and other silencing proteins recognize and 
differentiate between different repetitive elements and mediate their finetuned expression 
control. One of the best studied strategies is performed by proteins that recognize specific 
DNA sequences and thus mediate specific targeting. Notably, KAP1 itself cannot bind 
DNA directly but different KRAB-ZFPs have evolved to recognize different repetitive 
elements. KAP1 is recruited to the chromatin by the interaction of its RING-B box-coiled 
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coil (RBCC) domain with KRAB-ZFPs. KAP1 has a HP1-binding domain by which HP1 
is recruited, promoting heterochromatisation (Figure 1.4.2). It also has a PHD and 
bromodomain that interacts and recruits the histone methyltransferase SETDB1 which 
leads to H3K9me3 and, subsequently H4K20me3. HP1 in turn can bind H3K9me3, which 
reinforces the heterochromatin environment (Figure 1.4.2) (Iyengar and Farnham, 2011). 
KAP1 and the downstream silencing machinery discussed here is mainly employed in 
order to control class I and II ERVs, such as IAPs and VL30 elements.  
LINE1 elements (non-LTR retrotransposons) similarly encompass many actively 
transposing copies in the mouse (Goke and Ng, 2016; Jacobs et al., 2014; Robbez-Masson 
and Rowe, 2015). The most ancient LINE1 families are neither KAP1-bound nor DNA 
methylated in mES cells, likely they have accumulated mutations and are no longer active. 
The new families (3.8-7.3 million years old), however, are KAP1-bound, repressed and 
highly methylated, depicting an evolutionary dynamic L1 regulation (Castro-Diaz et al., 
2014; Robbez-Masson and Rowe, 2015). L1MdF and L1MdF2 are two examples of new 
L1 families in the mouse which are bound by KAP1 and de-repressed upon its removal 
(Castro-Diaz et al., 2014) 
Class III displays a different expression pattern. These elements are highly upregulated 
in early stages after fertilisation in the oocyte and downregulated again at the morula and 
blastula stages. An example of this class is the MERVL element which is derepressed in 
cells lacking the histone demethylase LSD1 (Macfarlan et al., 2011a), Rex1 
(Schoorlemmer et al., 2014) and the histone methyltransferase G9a (Leung et al., 2011), 
revealing a distinct mechanism than seen in class I and II ERVs. In the case of ERVs, the 
loss of KAP1 causes increased expression of the element in mES cells, but not in mouse 
fibroblasts (Cheng et al., 2014b; Iyengar and Farnham, 2011). This suggests that in some 
cell types, KAP1 may not be required for ERV repression or be redundant with other 
mechanisms. 
Other mechanisms play a role in the silencing of ERVs. As mentioned, DNA methylation 
plays a major role particularly in differentiated cells. However, there are ATP-dependent 
remodellers that have been implicated in the repression of repetitive elements in mES 
cells. The depletion of ATRX has been linked to the upregulation of class II and III ERVs 
(He et al., 2015), however its role remains debated, as is explained in detail in the 
discussion.   Chromodomain Helicase DNA Binding Protein 5 (CHD5)  is another 
example (Hayashi et al., 2016) and the enzymatic activity of Helicase, Lymphoid Specific 
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(HELLS), a Snf2-like factor, is required for de novo DNA methylation of IAPs (Ren et 
al., 2015). However, this was shown during differentiation and not in pluripotent ES cells. 
A role of ATP-dependent remodelling has not been reported in the control of ERVs in 
mES cells.  
 
1.4.1. The role of ERVs in gene regulation 
Retrotransposons can negatively affect genome stability and disrupt DNA sequences due 
to transposition. Therefore, it is important that they are maintained in a repressed state. 
Many ERVs are however no longer active but even their strict regulation is required, not 
to limit retrotransposition, but due the role of ERVs in gene regulation. Retroviral 
elements have frequently been co-opted by the cell to control genes. Transcriptome 
profiling of mammalian stem cells has shown this in pluripotency maintenance and 
embryogenesis (Fort et al., 2014).  
The exact mechanism by which ERVs, or truncated versions of them, are converted into 
regulatory sequences, remains obscure. However, they are uniquely suitably as cis-
regulatory elements (Thompson et al., 2016). Their LTRs harbour the regulatory regions 
required for proviral transcription, including combinations of transcription factor binding 
sites (Thompson et al., 2016). And indeed, ERVs evolve faster than other TEs: ERVs in 
humans and chimpanzees have acquired signatures of directional evolution since the 
species split ~5 million years ago (Gemmell et al., 2015). There are now several examples 
known of ERVs as regulators of cellular genes. ERV promoters can drive the expression 
of tissue-specific genes, such as MERVL LTRs which serve as primary or alternative 
promoters of nearby genes (Macfarlan et al., 2011b), or an ERV that sits adjacent to the 
transcriptional start site of the mouse Sex-limited protein (Slp)-gene and dictates 
androgen-dependent regulation of this gene (Stavenhagen and Robins, 1988). Many of 
these ERVs functioning as tissue-specific promoters are unmethylated, bound by TFs and 
marked by H3K4me3, H3K27ac and H3K9ac (Bourque et al., 2008; Marino-Ramirez and 
Jordan, 2006). ERVs have further been shown to function as enhancers and they can even 
be integrated directly into existing genes increasing isoform diversity and influencing 
posttranslational regulation (Goke and Ng, 2016; Sorek et al., 2002; Zemojtel et al., 
2007), but the adaptive consequences of this process for specific physiological functions 
remain largely unexplored. 
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1.5. KAP1 in mouse ES cells  
Among the many functions KAP1 has in ES cells, apart from its role in ERV silencing, 
is the role it plays in both constitutive and facultative heterochromatin. Together with the 
chromatin remodeller SMARCAD1 (SWI/SNF-Related, Matrix-Associated Actin-
Dependent Regulator of Chromatin, Subfamily A, Containing DEAD/H Box 1) it is 
involved in the maintenance of pericentric heterochromatin. In somatic cells 
SMARCAD1 and KAP1 bind to pericentric foci and are crucial to establish 
heterochromatin after replication (Rowbotham et al., 2011).  
On Zfp genes KAP1 is required for heterochromatisation. ZFP274 recruits KAP1 to the 
3’ end of a Zfp gene (Frietze et al., 2010). Surprisingly, there is no correlation between 
the level of KAP1 at Zfp genes and the expression of that gene (Blahnik et al., 2011), thus 
it may not be transcription that is the target of KAP1-induced heterochromatisation. Zfp 
genes are highly homologous, having arisen from genomic duplications (Emerson and 
Thomas, 2009) and their 3’-coding exons encode tandemly arranged highly repetitive zinc 
finger domains. It has been suggested that KAP1 is involved in suppressing 
recombination at these sites, and interestingly binding of KAP1 positively correlates with 
the number of repeated zinc fingers within the Zfp 3’-exons (Blahnik et al., 2011).  
KAP1 also plays a central role in genomic imprinting in the mouse, together with ZFP57. 
ZFP57 null mice show embryonic lethality and loss of imprinting at many, but not all 
loci. ZFP57 binds to co-factor KAP1 which recruits major repressive epigenetic 
regulators (SETDB1, HP1) (Li et al., 2008). Furthermore, its binding is sequence- and 
DNA methylation-specific and thus allows for allelic binding of KAP1 and further 
heterochromatisation potentially safeguards imprints from DNA demethylation waves 
(Quenneville et al., 2011; Strogantsev et al., 2015).     
 
1.6. Chromatin remodelling by SMARCAD1 and roles in repression 
The SWI/SNF-Related, Matrix-Associated Actin-Dependent Regulator of Chromatin, 
Subfamily A, Containing DEAD/H Box 1 (SMARCAD1) family of remodellers is one of 
the most conserved families. It includes Function Unknown Now-30 (Fun30) 
in Saccharomyces cerevisiae, Fission yeast Fun Thirty-3 (Fft3) in Schizosaccharomyces 
pombe, and SMARCAD1/Etl1 in mammals. The yeast protein has been biochemically 
well characterised and was shown to bind both DNA and chromatin and its ATPase 
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activity is similarly stimulated by both DNA and chromatin (Awad et al., 2010). Budding 
yeast Fun30 was shown to possess ATP-dependent chromatin remodelling activity in 
assays in vitro where its ability for histone dimer exchange was slightly higher than 
nucleosome repositioning (Awad et al., 2010). Based on sequence homology the Fun30 
protein is most closely related to the Swr1 and Ino80 proteins (Flaus and Owen-Hughes, 
2011) both of which show activity in histone exchange (Mizuguchi et al., 2004; 
Papamichos-Chronakis et al., 2006). Additionally, it was shown that Fun30 represses 
transcription by sliding promoter-proximal nucleosomes in an ATP-dependent manner 
(Byeon et al., 2013). And yet another study revealed a role of Fft3 in the disassembly of 
nucleosomes at transcribing regions to facilitate transcription elongation (Lee et al., 
2017). Hence, the SMARCAD1 homologs in yeast have been implicated in several 
mechanisms of remodelling, ranging from histone dimer exchange, nucleosome 
repositioning to nucleosome disassembly. 
When it comes to their function, SMARCAD1 homologs are important in 
heterochromatin maintenance. In S. cerevisiae Fun30 is required for the silencing of 
reporter genes embedded within transcriptionally repressed domains (Neves-Costa et al., 
2009). Interestingly, its ATPase function is critical for repression since mutating an 
essential lysine residue in the ATPase domain abolishes this function (Neves-Costa et al., 
2009). The SMARCAD1 homolog Fft3 in fission yeast is localized to centromeric 
insulators at the subtelomeric transition zone where it is similarly essential to maintain 
chromatin structure by inhibiting euchromatin assembly in silent domains (Stralfors et 
al., 2011). In fission yeast there is a well-known insulator element; two inverted repeats 
called IRCs that flank the border of the centromeres 1 and 3 (Cam et al., 2005). Fft3 binds 
these insulator elements and in its absence euchromatin marks, such as histone acetylation 
and the histone variant H2A.Z, invade centromeres and subtelomeres which results in 
misregulated gene expression and chromosome segregation defects (Stralfors et al., 
2011). Fft3 is also localized to the LTR elements at the borders of subtelomeres in fission 
yeast (Steglich et al., 2015). LTR elements can function as insulators, as has been shown 
in the mouse (Carabana et al., 2011). When Fft3 is removed the nucleosome occupancy 
over the LTR elements is reduced at the subtelomeric border (Steglich et al., 2015). This 
suggests that Fft3 maintains chromatin structure, specifically of heterochromatic 
domains, by binding and remodelling nucleosomes at defining regulatory elements. 
Interestingly, this heterochromatic role of SMARCAD1 homologs is not restricted to 
Fft3. Fun30 shows a similar role in budding yeast even though the centromere structure 
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is vastly different. Budding yeast has defined point centromeres that are not embedded in 
heterochromatin. Similarly, to fission yeast, Fun30 is enriched at centromeres where us 
suppresses transcriptional noise, and it is required for normal nucleosome positioning and 
occupancy surrounding the centromeric nucleosome. Fun30 is involved in supporting 
faithful chromosome segregation through its role in determining centromeric and 
pericentromeric chromatin. And similar to Fft3, Fun30 is found binding over LTRs and 
telomeric repeats, among others (Durand-Dubief et al., 2012). 
In human somatic cells SMARCAD1 acts together with the co-factor KAP1 to establish 
and maintain heterochromatin, specifically histone hypoacetylation and H3K9 
methylation, during replication-coupled chromatin assembly (Rowbotham et al., 2011). 
SMARCAD1 is recruited to sites of DNA replication, interacts with HDAC1/2, G9a, 
PCNA and HP1, is required for KAP1 and HDAC1 binding to pericentric 
heterochromatin, and upon its loss there is a global reduction of H3K9me3 and HP1, and 
an increase of H3ac. These changes cannot be rescued by a SMARCAD1 ATPase mutant 
and they are linked to the progression through S-phase (Rowbotham et al., 2011). This 
illustrates that in somatic cells SMARCAD1 is required for the perpetuation of silenced 
loci since upon its loss the cells show mitotic defects and chromosome segregation is 
perturbed (Rowbotham et al., 2011). The cooperation of SMARCAD1 with KAP1 is not 
restricted to somatic cells. In both mouse ES cells and human somatic cells KAP1 is a 
stoichiometric partner of SMARCAD1 (Ding et al., 2018; Rowbotham et al., 2011). The 
interaction was mapped to the RBCC domain of KAP1 and the Coupling of Ubiquitin to 
ER degradation (CUE1) domain of SMARCAD1 and this interaction is required for the 
nuclear retention of SMARCAD1 (Ding et al., 2018). When it comes to the role of 
SMARCAD1 in ES cells it should be of note that SMARCAD1 levels are very high in 
the inner cell mass of the embryo at blastocyst stage (Schoor et al., 1993) and also in ES 
cells in culture when compared to somatic cells (Sachs et al., 2019; Xiao et al., 2017). 
Upon the loss of SMARCAD1 ES cells lose their typical morphology and show defects 
in the exit from self-renewal (Sachs et al., 2019; Xiao et al., 2017). In accordance with 
this observation the pluripotency marker Nanog and Oct4 are reduced upon the loss of 
SMARCAD1 as is the stem cell marker alkaline phosphatase (Sachs et al., 2019). 
SMARCAD1 and its homologs thus play conserved and crucial functions in 
heterochromatin maintenance and assembly. Additionally, both Fun30 and SMARCAD1 
promote long-range DNA end resection during repair of DNA double-strand breaks 
38 
 
(DSBs) (Chen et al., 2012; Costelloe et al., 2012; Eapen et al., 2012). DNA end resection 
is the initiation of the homologous recombination pathway upon DNA damage.  
 
1.7. Objectives 
The chromatin remodeller SMARCAD1 has emerged as an interesting factor in the 
context of pluripotency. The diverse functions of its orthologs point towards diverse 
potential roles of SMARCAD1 in the chromatin of ES cells. The objective of this study 
is to elucidate these functions with a focus on the genome-wide binding of SMARCAD1.  
The first aim of this study is to establish a robust protocol for ChIP-seq with the 
endogenous protein SMARCAD1 as well as with stable FLAG-SMARCAD1 clones. The 
FLAG and the endogenous ChIP-seq were used to investigate the categories of 
SMARCAD1 binding sites genome-wide in pluripotent cells. In order to understand the 
function of SMARCAD1 in ES cells its binding sites were determined. Histone marks 
and other chromatin modifiers were investigated for enrichment on SMARCAD1 binding 
sites. The recruitment of SMARCAD1 to chromatin was another aim of this study, a 
KAP1-interaction mutant was employed to determine whether SMARCAD1 recruitment 
to different categories of its binding sites is dependent on its interaction with KAP1.  
A loss-of-function approach was employed on subcategories of SMARCAD1 binding 
sites to determine the effect SMARCAD1 has on other co-factors involved in repression. 
The main focus was on the role of SMARCAD1 on repetitive regions such as endogenous 
retroviral elements. The function of SMARCAD1 was further elucidated on endogenous 
retroviruses by employing and ATPase mutant of the protein to determine whether its 
function on these sites is dependent on chromatin remodelling by observing the effect of 
the mutant on the binding of several repressive co-factors. 
SMARCAD1 binding was investigated in differentiated ES cells since its protein 
interaction partners are very conserved in ES and somatic cells, as is its function in 





2. Materials and Methods 
2.1. Tissue culture techniques 
2.1.1. Cell lines and media 
PGK12.1 female mouse ES cells were used to make the stable cell lines expressing 
FLAG-SMARCAD1-WT and FLAG-SMARCAD1-ATPase mutant and their respective 
empty vector control for ChIP-seq. A stable SMARCAD1 knockdown of this cell line 
was also used for ChIP-seq and for ES cell differentiation. 
E14 male mouse ES cells containing various SMARCAD1 constructs were used for a 2-
day and 4-day inducible knockdown of SMARCAD1. E14 cells were also used for a 3-
day transient knockdown of KAP1. A stable knockdown of SMARCAD1 in this cell line 
was used in ChIP experiments. 
All three mouse ES cell lines and controls were routinely cultured in feeder-free 
conditions on gelatin-coated cell culture flasks, in the LIF+serum medium. Cells were 
routinely tested using MycoAlertTM Mycoplasma Detection Kit (Lonza Bioscience, cat. 
no. LT07-418) to ensure they were free of mycoplasma.  
 
ES cell growth medium: Leukaemia Inhibitory Factor (LIF) + serum  
Reagent Volume 
DMEM (Gibco 41965-039) 500 mL 
Fetal Bovine Serum (Batch tested for mouse ES cell in the laboratory) 75 mL 
L-Glutamine 200 mM (Gibco 25030-024) 5 mL 
MEM Non-Essential Amino Acids (100×) (Gibco 11140-035) 5 mL 
β-Mercaptoethanol (50 mM) (Gibco 31350-010) 570 µL 
LIF, mouse recombinant (107 units/mL) (Cell GS GFM200) 57.5 µL 
Penicillin/streptomycin (pen/strep) (Gibco 15140-122) (optional) 5 mL  
 
LIF serum-free medium 
The serum-free medium was used in transfection experiments. All the reagents besides 
serum were mixed as making the LIF+serum medium. An aliquot (50 or 100 mL) from 




EC10 medium (for ES cell differentiation) 
Reagent Volume 
DMEM (Gibco 41965-039) 500 mL 
Fetal Bovine Serum (Batch tested for mouse ES cell in the laboratory) 75 mL 
L-Glutamine 200 mM (Gibco 25030-024) 5 mL 
MEM Non-Essential Amino Acids (100×) (Gibco 11140-035) 5 mL 
β-Mercaptoethanol (50 mM) (Gibco 31350-010) 570 µL 
Pen/strep (Gibco 15140-122) (optional) 5 mL  
 
Medium for mouse embryonic fibroblasts (MEFs) 
Reagent Volume 
DMEM high glucose (4.5g/L) (Gibco 11965-092) 250 mL 
Ham’s F-10 (Gibco Thermo Fisher Scientific) 250 mL 
Fetal Bovine Serum (Batch tested for mouse ES cell in the laboratory) 100 mL 
Pen/strep (Gibco 15140-122) (optional) 5 mL  
 
2.1.2. Gelatin coating 
ES cells were grown feeder-free in cell culture vessels. This was achieved by coating the 
vessels with 0.1% gelatin (Sigma, cat. no. G1890-100G) in Phosphate Buffered Saline 
(PBS). The gelatin was applied for a minimum of 5 minutes at room temperature and the 
remaining liquid removed shortly before use via aspiration. 
 
2.1.3. Growing and splitting cells 
ES cells were fed with fresh medium every 24 hours and routinely passaged at confluence 
90%. Usually, ES cells were split 1:4 to 1:6 every 48 hours. For passaging, medium was 
aspirated off, cells washed in 1xPBS and detached using 0.05% trypsin-EDTA (Gibco, 
cat. no. 25300-054). The cells were dissociated at toom temperature for 3 minutes. 
Trypsin was inactivated with fresh medium containing serum and the cells were 




2.1.4. Freezing cells 
Cells were typsinised as described for splitting and the trypsin inactivated with freezing 
medium (FCS with 10% DMSO). The suspension was carefully mixed by minimal 
pipetting and divided into cryogenic tubes. For this, 1.5mL were transferred into 1.8mL 
cryotubes and transferred to a freezing container (Mr. Frosty™) filled with isopropanol. 
Usually, mouse ES cells from a cell culture vessel with 80% confluence were frozen down 
into two vials, each of which could be recovered in a vessel of the original size. The 
containers were immediately placed at -80 °C and let to cool down overnight until the 
cells in the cryogenic tubes were frozen. For long-term preservation, they were then 
placed in liquid nitrogen containers. 
 
2.1.5. Thawing cells 
Cells frozen in cryogenic tubes were thawed in a warm water bath until defrosted. They 
were then gently transferred into 15 mL falcon tubes containing 10 mL of fresh growth 
medium. The cells were pelleted by centrifugation (300 g x 3 minutes) and the medium 
was removed by aspiration. The cells were then resuspended in a small amount of medium 
and plated into pre-gelatin coated cell culture vessels containing the appropriate amount 
of medium  
 
2.1.6. Stable cell lines 
Cells Constructs Treatments 
PGK12.1  FLAG-empty vector control 1µg/mL puromycin 
 FLAG-SMARCAD1-WT 1µg/mL puromycin 
 FLAG-SMARCAD1-ATPase mt 1µg/mL puromycin 
 Stable SMARCAD1 kd 1µg/mL puromycin 
 Control kd 1µg/mL puromycin 
E14 Stable SMARCAD1 kd 1µg/mL puromycin 





2.1.7. Eccentricity assay with IncuCyte real live imaging  
For observing cell growth and stemness in real time cells were plated in triplicates at 
dilutions ranging from 10 000 cells to 312 cells per well on 96 well tissue culture plates 
and incubated at 37 °C. Photomicrographs were captured every three hours using an 
IncuCyte cell live imager (Essen BioScience) and the IncuCyte ZOOM’s Confluence 
Processing analysis tool was used to calculate cell confluence metrics in real-time, 
specifically the eccentricity of the cells defined as the average of how round or compact 
the objects are ranging from 0 to 1 with a perfect circle having a value of 0. 
 
2.1.8. ESC differentiation 
PGK12. ES cells were plated in non-gelatinised 10 cm2 cell culture vessels, 10-15 plates 
per cell line. Cells were trypsinised and the reaction stopped with EC10 medium. They 
were counted with the Casy Model TTC (Roche) and 8x105 cells were plated on each 
vessel in 10 mL EC10 medium. The cells were left to aggregate for three days and the 
EC10 medium changed daily. On the third day they were blown off using a pipette boy 
and 10 mL pipette tips. Without gelatin they are easily detachable and were collected in 
50 mL falcons. The cells from 5 plates were collected in one 50 mL falcon. The cells were 
left to settle without centrifuging and the medium gently aspirated. They were transferred 
to sterile 10 cm2 bacterial plates in 10 mL EC10 medium and left to grow in suspension 
where they form embryoid bodies. The EC10 medium was changed daily by transferring 
the cells in suspension to 50 mL falcons, aspirating the medium off after the cells had 
settled and transferring them into fresh medium. Importantly, the cells were not 
centrifuged since this tends to break apart the embryoid bodies and differentiation is not 
successful. After five days of differentiation the cells were collected and used in a ChIP 
experiment in suspension. 
 
2.1.9. Cell pellets 
Cells were trypsinised as described and neutralised in medium containing serum. They 
were transferred into tubes and kept on ice. The cells were pelleted by centrifugation 
(2000 x g, 3 min, 4 °C) and the medium was removed. The cell pellet was resuspended in 
cold PBS supplemented with 0.1 mM PMSF and 0.1 mM benzamidine and pelleted again 
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by centrifugation. The PBS was removed and the washing step repeated. Afterwards, the 
cell pellet was snap-frozen in liquid nitrogen and stored at -80 °C.  
 
2.1.10. Transfection and stable clones 
Stable FLAG-SMARCAD1 and control cell lines were generated encoding 3xFLAG-
SMARCAD1, 3xFLAG-ATPase mutant and a non-target control containing only 
3xFLAG.  
PGK12.1 ES cells were transfected using Lipofectamine 2000 (Life Technologies) 
following manufacturer’s instructions. A GFP-vector was used as a control for the 
transfection (see plasmid list/plasmid maps). 1x106 cells were plated per well in a 6-well 
tissue culture dish on the day of the transfection. The transfection was executed in 
suspension, per transfection 4μg of purified plasmid DNA diluted in 250μl serum-free 
DMEM was mixed with 8μl Lipofectamine 2000 diluted in 250μl serum-free DMEM. 
The mixed solution was incubated at room temperature for 20 minutes and then added to 
the ES cells and the cells were placed in a humidified CO2 incubator at 37 °C. After 5 
hours, the medium was replaced with fresh ES cell medium containing serum. Twenty-
four hours after transfection the cells were split in different dilutions into four 100 mm 
dishes. Antibiotic selection with 1.7 μg/ml puromycin to generate stable cell lines was 
started 48 hours after transfection and the cells were kept under selection for 10-13 days. 
Untransfected cells were treated the same way and were used as a selection control. After 
selection, the cells were picked as colonies or grown as pool. The obtained cell lines were 
expanded and analyzed by Western blot and indirect immunofluorescence. 
 
2.1.11. Colony picking 
Each 100 mm dish with colonies to be picked was washed with PBS and 3ml PBS were 
added to the plate to stop the cells from becoming too dry. Individual colonies were 
picked and transferred to 25µl trypsin diluted ½ in 1xPBS in a well of a 96 well plate. 
Once the entire plate was picked it was incubated for 10‐15 min in a CO2 incubator at 37 
°C. Cells were resuspended and transferred to a pre‐prepared 96 well plate with fresh 




2.1.12. Cloning out using Li-Cor In-Cell WesternTM 
In order to increase the level of expression of the FLAG-SMARCAD1-ATPase mutant 
construct the stable cell line was cloned out using 96-well plates and In-Cell Western by 
Li-Cor for fast processing. Initially, a T75 of clone 8 was diluted to 5x104 cells/mL and 
200 µL of this dilution transferred to each 96-well. The empty vector cell line as well as 
the FLAG-SMARCAD1-WT cell line were used as negative and positive controls, 
respectively. The levels of construct expression were determined via FLAG detection 
according to the manufacturer’s protocol. Briefly, the medium was aspirated off and the 
cells in the wells were fixed and permeabilized as described for the FLAG antibody in 
the section on immunofluorescence. A multichannel pipette was used for all steps and the 
cells are not left to dry out at any point in the protocol until imaging. 150 µL of OdysseyTM 
blocking buffer is used after fixation and permeabilization for 1.5 hours at room 
temperature. Afterwards, the primary antibody is diluted in blocking buffer as described 
(2.9 key resource tables) and 50 µL are applied for two hours at room temperature on a 
shaking platform. Wells with no primary antibody are used in every experiment as 
negative control. The wells are washed thrice with PBS and 50 µL of the secondary 
antibody are applied (2.9 key resource tables) for one hour at room temperature on a 
shaking platform while the plate is kept protected from light. The cells are washed again 
thrice with PBS and the last wash is removed completely. The FLAG expression was 
determined with Li-Cor In-Cell Western imaging as described by the manufacturer with 
the wavelength setting appropriate for the secondary antibody that was employed. The 
highest expressing well was selected and expanded to a T75 and the procedure was 
repeated until a robust expression of the FLAG-construct was achieved (in comparison to 
the WT construct) 
 
2.1.13. Transient knockdowns (KAP1 and SETDB1) 
Transient knockdown of KAP1 and SETDB1 was performed in order to carry out ChIP 
experiments. E14 WT ES cells were employed for both transient transfections. The cells 
of the transient KAP1 knockdown were collected three days after the initial transfection. 
The cells in the transient SETDB1 knockdown were collected four days after transfection 
and a re-transfection was performed at day two. The transfection protocol was upscaled 
from the protocol described in the generation of stable FLAG-SMARCAD1 clones. 
Briefly, the transfection is carried out in 15 cm2 cell culture dishes with 20x106 cells per 
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dish in 12 mL medium. The shRNA is upscaled to 64 µg per dish and prepared in 4 mL 
serum-free medium as are the 128 µL of lipofectamine. After complex formation the 8 
mL serum-free medium containing the complexes are added drop by drop onto the cells 
and left for five hours as described in the transfection subheading. Puromycin selection 
is started the next day at 1.4 µg/mL. For ChIP the cells of both transfections were plated 
24 hours before crosslinking as described in the protocol for ChIP with adherent cells. 
 
2.2. Chromatin Immunoprecipitation   
 
2.2.1. ChIP in adherent cells 
Chromatin immunoprecipitation was used to identify the genome-wide binding sites of 
chromatin factors (ChIP-seq) and to validate the ChIP-seq results (ChIP-qPCR). ChIP 
assays were performed using the One Day ChIP kit (Diagenode). 25x106 embryonic stem 
cells were plated in 150 mm dishes 24 hours prior to crosslinking. This resulted in ~50 
million cells per plate for crosslinking. Preceding the fixation step, cells were washed 
with three times with 1xPBS. Ten ml of 1xPBS was added per dish and 
Disuccinimidylglutarate (DSG) freshly resuspended in DMSO was added to a final 
concentration of 2 mM. The cells were fixed for 45 minutes at room temperature on a 
shaking platform. Following the fixation, the cells were washed three times with 1xPBS 
and a second crosslinking step was performed with 1% Formaldehyde in PBS for 10 
minutes at room temperature. The crosslinking was stopped by the addition of glycine to 
a final concentration of 0.125 M for 5 minutes at room temperature. The cells were 
washed twice with ice-cold 1xPBS, scraped off in wash buffer B (10 mM HEPES/KOH 
pH 6.5, 10 mM EDTA, 0.5 mM EGTA, 0.25% Triton X, protease inhibitors PMSF and 
Benzamidine) and collected in 15 ml conical Falcon tubes. From here on everything was 
performed on ice. The cells were then pelleted by centrifugation at 2000 rpm at 4 ºC, 
resuspended in wash buffer C (10 mM HEPES/KOH pH 6.5, 10 mM EDTA, 0.5 mM 
EGTA, 200 mM NaCl and protease inhibitors PMSF and Benzamidine) and incubated 10 
minutes on ice. They were again pelleted by centrifugation at 2000 rpm at 4 ºC and 
resuspended in lysis buffer D (50 mM Tris/HCl pH 8.0, 10 mM EDTA, 1% SDS, Protease 




The samples were incubated for 20 minutes on ice before sonication. Sonication was 
performed using a Bioruptor sonicator (Diagenode) to generate fragments between 200-
600 basepairs (bps). Typically, 20-25 sonication cycles of 30 seconds on and 30 seconds 
off were performed for ES cells. The sonicated chromatin was centrifuged for 10 minutes 
at 13000 rpm at 4 ºC in 1.5ml Eppendorfs. The supernatant was transferred into a new 
tube and the chromatin concentration was determined using a Nanodrop. 
Fragment sizes were analysed by taking a 6 μl aliquot, incubating it for 30 minutes with 
RNAse at room-temperature, after which 8μl 5M NaCl were added o/n at 65 °C. 
Afterwards, Proteinase K treatment was performed for 1h and 50 minutes at 45 °C. The 
samples were then Phe/CHCl3 extracted and the upper phase was run on a 1.2 % agarose 
gel. If fragment sizes were lower than 1 kb the procedure was continued. The sheared 
chromatin was stored at -80 °C.  
43 μl protein A beads (OneDay ChIP kit Diagenode) were used per ChIP, corresponding 
to ~50 million cells. They were washed twice in ChIP buffer (OneDay ChIP kit) before 
immunoprecipitation. Chromatin corresponding to 100 μg of DNA was used for each 
ChIP. The sonicated chromatin was diluted ~1:5 in ChIP buffer. Samples were incubated 
with 3 µg of antibody for 2-3 hours on a rotating wheel at 4 °C. A 10-minute 
centrifugation step at 13,000 rpm was performed and the antibody-bound chromatin was 
collected and added to the protein A beads. Samples were incubated for 1 hour on a 
rotating wheel at 4 °C and subsequently washed twice with ChIP buffer from the OneDay 
ChIP kit. To elute the bound DNA the beads were resuspended in DNA purifying slurry 
(OneDay ChIP kit) and boiled for 10 min. The samples were incubated for 30 min with 1 
μl Proteinase K on a ThermoMix at 550 rpm and subsequently boiled at 95 °C for 10 
minutes to inactivate the proteinase K. The samples were centrifuged at 13,000 rpm and 
the DNA collected in 200 μl PCR-clean water.  
 
2.2.2. ChIP in solution 
Cells were plated 24 hours before crosslinking as described in the ChIP protocol for 
adherent cells. They were trypsinised immediately before crosslinking and collected in a 
50 mL falcon. For ES cell differentiations the cells were collected directly from the 
bacterial dishes without trypsinization. The DSG was prepared as described in the ChIP 
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protocol on adherent cells, and the cells washed thrice with PBS. 10 mL of DSG-PBS 
was added for each dish (~40-50x106 cells) to the 50 mL falcon. For ESC differentiation, 
10 mL DSG-PBS was added for four bacterial dishes. The falcons were rolled for 45 
minutes at room temperature, the DSG-PBS was removed after brief centrifugation at 
1,000 rpm, and the cells washed thrice in PBS. 10 mL PBS was added for each dish of 
cells collected initially (e.g., 30 mL for three dishes). Formaldehyde was added to a final 
concentration of 1% in PBS and the falcons were rolled for 10 minutes at room 
temperature. The reaction was stopped with glycine at a final concentration of 125 mM 
for 5 minutes at room temperature. The crosslinked cells were washed twice in cold PBS 
and resuspended in cold buffer C from the OneDay ChIP kit (Diagenode) and the 
experiment was carried out as described for ChIP in adherent cells.      
 
2.2.3. Re-ChIP 
Sequential ChIP was performed using SMARCAD1 (3 µg) or KAP1 (3 µg) antibody in 
the first round as described in the ChIP protocol, precipitated material was eluted twice 
from the beads with elution buffer containing 10 mM DTT, 100 mM NaCL, and 1% SDS 
at 37 °C for 30 min. The eluted DNA was diluted 40-fold with ChIP buffer, and a second 
round of immunoprecipitations was performed in accordance with the OneDay ChIP kit 
(Diagenode) manual, performing an overnight antibody (6 µg) incubation at 4 °C of 
SMARCAD1, KAP1 and IgG antibody.  
 
2.2.4. Real-time qPCR after ChIP 
qPCR analysis was performed on DNA obtained from ChIP experiments. 4μl DNA was 
added together with 1x iQ SYBR Green supermix (Bio-Rad) and 0.5μM forward and 
reverse primers. A sample with water instead of DNA was used to rule out primer dimer 
formation and other contamination. Primers are listed in the key resources table. 
qPCR conditions were as follows: 10 minutes at 95 °C followed by 40 cycles at 95 °C for 
15 seconds and 60 °C for 30 seconds, followed by a plate read after each cycle. Melting 
curve test was performed at the end of each experiment (from 55 °C to 95 °C, read plate 




qPCR was executed on a CFX96 Connect (Bio-Rad) or an Agilent MX3000P. Enrichment 
values for specific factors were normalized to input and plotted either as % input using 
the standard error of technical replicates or as fold change over H3 (for histone 
modifications), using error propagation:  
𝐸𝑟𝑟𝑜𝑟 𝑝𝑟𝑜𝑝𝑎𝑔𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑆𝐸 = 
(𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 𝑜𝑣𝑒𝑟 𝐻3 × √(𝑆𝐸 ÷ 𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑖𝑛𝑝𝑢𝑡)2 + (𝑆𝐸 𝑜𝑓 𝐻3 ÷ 𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑖𝑛𝑝𝑢𝑡 𝐻3)2).  
 
2.2.5. Primer Design and testing 
Primers were designed with PrimerBlast using mouse genome sequences from the UCSC 
Genome browser and in silico PCR was used to test initial specificity. Primers were 
designed to be 180‐210 bp, with melting temperatures of 58‐62 C°, 20‐28 bp long, with 
GC content of 20‐80 %, and with no more than 3 out of 5 bases at 3’ end with G or C. For 
primers amplifying repetitive sequences the automatic repeat filter was removed. qPCR 
primers were tested on genomic DNA and resolved by gel electrophoresis. Each primer 
pair was tested for efficiency and quantification with serial 10‐fold dilutions of genomic 
DNA. Only primers with a defined melting curve and good efficiency (80-120%) were 
used in subsequent experiments. Primers that yielded unspecific bands on the agarose gel 




For each ChIP-seq, up to seven ChIP samples were pooled during DNA purification in 
order to have enough material for library preparation and amplification. Otherwise, the 
ChIP was carried out as described. During DNA purification the chromatin was eluted 
from the antibody binding beads (OneDay ChIP kit Diagenode) using 230 µL elution 
buffer (100 mM NaHCO3 ,1% SDS, freshly prepared and sterile filtered). The beads were 
incubated for 30 minutes at room temperature while shaking on a ThermoMix 
(Eppendorf). They were centrifuged at 13,000 rpm for 1 minute and 200 µL of the 
supernatant was collected. The beads were discarded. The chromatin was de-crosslinked 
overnight with 8 µL NaCl at 65 °C. 8 µL 1M Tris/HCl pH 6.5, 4 µL 0,5 M EDTA and 2 
µL Proteinase K (10 µg/µL) were added for 1 hour at 45 °C to digest the proteins. For 
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DNA purification the QIAquick PCR Purification Kit (Qiagen) was used according to the 
manufacturer’s instructions and all the samples pertaining to the same antibody were 
pooled via the same DNA binding column and eluted from the column with 40 µl sterile 
2 mM Tris/Cl, pH8.5. Of each sample 1 µL was measured using the Quant IT kit 
(Invitrogen) on the FluoroNanoDrop and the samples stored at -20 °C. 
   
2.3.1. Library preparation and sequencing 
Library preparation was performed using the MicroPlex Library Preparation Kit v2 
(Diagenode) according to manufacturer’s instructions and all reagents used were made 
freshly and sterile filtered. The bench and all instruments used were cleaned with bleach. 
Briefly: 4-8 ng DNA was used for each sample. The MicroPlex Library Preparation kit 
provides adapters to sequence and identify different samples. This adapter-ligated DNA 
was amplified on a thermal cycler with up to 9 cycles of PCR amplification before size 
selection and DNA purification with AMPure XP beads (Agencourt). Size and 
concentration of the DNA fragments was assessed on a Bioanalyzer (Agilent 
Technologies) by the sequencing facility. Sequencing was performed in the Genomics 
Core Facility of the Philipps-Universität Marburg on the Illumina 1500 platform with on-
board cluster generation using the HiSeq Rapid SR Cluster Kit v2 (Illumina) and single 
read 50 nucleotide sequencing on a HiSeq Rapid SR Flow Cell v2 (Illumina). 
 
2.3.2. Data analysis 
Data analysis was performed by Boris Lamp. Reads from the sequencing were aligned to 
the Mus Musculus genome version mm10 retrieved from Ensembl revision 83 using 
Bowtie 2.0.0-beta7 (Langmead and Salzberg, 2012), and with the default parameter 
settings. After all reads were aligned to sequences in the genome the laned were de-
duplicated to the expected number of duplicate reads for a given region based on binomial 
distribution. Only these reads were kept for further analysis. Peak calling was performed 
for each ChIP-seq separately and for each antibody an IgG antibody or input or both was 
used as control. The MACS program v1.4.0rc2 (Zhang et al., 2008) was used for all 
samples, except for the histone modification mark H3K9me3. H3K9me3 ChIP peaks 
were called using SICER 1.1 (Zang et al., 2009) with these parameters: windows size 
200, gap size 200, fragment size 51, mappability percentage 0.78. Only those peaks were 
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kept that were not present in the backgrounds (IgG or input, or if present, both). Peak 
filtering was used in order to reduce false positive peaks. This was achieved by identifying 
only those peaks that show a strong enrichment over their backgrounds. SMARCAD1 
and KAP1 peaks were only retained if they had a minimum of 30 effective foreground 
reads, not more than 50 effective reads in either of their background(s), and showing at 
least a 2.5-fold increase in the normalized read counts (TPM) compared to their 
background(s). For H3K9me3 only peaks with a minimum increase of three-fold in the 
normalized read counts compared to either of their backgrounds were kept. To permit 
comparison between the samples, tag counts were calculated and normalized to one 
million mapped reads (TPM, tag per million). The foreground-background ratio 
employed to filter reported peaks was determined on basis of TPMs in foreground versus 
those in the background. If more than one background value was available the ratio was 
calculated using the maximum background TPM value from either input or IgG antibody. 
To determine the genomic distribution of SMARCAD1 in the murine genome of stem 
cells the overlapping peaks from both the endogenous and the FLAG-ChIP-seq were 
taken into consideration if their left most position overlaps with defined genomic 
elements. The percentage of overlap was calculated and plotted. The annotations were 
taken from the Ensembl Genome database (Mus musculus, Rev. 83, mm10). Heatmaps 
were generated to compare the enrichment of the signal of the most pronounced peaks 
from SMARCAD1-FLAG and from the endogenous ChIP-seq. To each other but also to 
other chromatin factors. Regions spanning 1kb around the 2380 peaks (overlap of the two 
ChIP-seqs) were centred to the summit of the SMARCAD1-WT signal (TPM). For the 
different heatmaps to be comparable, all signals were normalized to TPM with the 98th 
percentile of the SMARCAD1-wt signal set as the maximum value. Darker colors 
indicate higher signal intensities. The expression heatmap was generated in Excel 
(Microsoft) using the function of Conditional Formatting on the log2 fold changes. 
Publicly available external ChIP-Seq data was obtained from GEO using the following 
accession numbers: GSM1555120 (KAP1), GSM1429923 (KAP1 input), GSM307622 
(H4K20me3), GSM1033638 (H3K27me3), GSM594578 (H3K27ac), GSM1033636 
(H3K4me3), GSM1555116 (H3.3), GSM459273 (SETDB1), GSM1215219 (G9a), 
GSM1375157 (SUV39H1), GSM1375158 (SUV39H2). For all screenshots depicted was 
well as for the manual inspection of the sequenced reads and peak distribution the 
Integrative Genomics Viewer (IGV) (Robinson et al., 2011) was used by myself and other 
members in the lab. Area proportional Venn Diagrams displaying overlap between peaks 
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from different datasets were generated by Philipp Bergmaier using eulerAPE (Micallef 
and Rodgers, 2014). 
 
2.3.3. Analysis of repetitive elements 
For the analysis of SMARCAD1 peaks in repetitive elements the method from (Elsasser 
et al., 2015) was employed by Boris Lamp. Briefly, for the alignment the annotated 
repetitive regions from Repeatmasker were downloaded from UCSC Table Browser 
(http:\\genome.ucsc.edu ) for mm10 on April 17th, 2017. The mm10 genome build was 
filtered to these regions to generate repetitive element sequences. All repeat sequences 
were expanded at their beginning and their end by one average read length (51 bp) in 
order to compensate for repeat elements that might be too short for correct read alignment. 
A bowtie index was created using bowtie-build and ChIP-seq reads were aligned against 
these repeat sequences using Bowtie (parameters: -k 1 and --best) (Langmead et al., 
2009). For the analysis of these aligned reads normalized read counts (TPM) were 
calculated for each repetitive element. Log2 fold-change over input was calculated for all 
repeat classes to identify elements enriched for SMARCAD1. The boxplot depicts the 
log2 fold-changes over input for all regions belonging to each of the custom repeat 
categories and the repeat class with the highest (averaged) fold-change. The box- and 
jitterplot depicts the log2 fold-changes over the corresponding input for all repeat regions 
belonging to each of the custom repeat categories. 
 
2.4. Protein work 
 
2.4.1. Total protein extraction 
Frozen cell pellets were thawed quickly and immediately re-suspended in 3-4x pellet 
volume of the lysis/digestion mix (20 mM HEPES [pH 7.3], 10 mM KOAc, 5 mM 
NaOAc, 2 mM MgOAc, 1 mM EGTA, 2 mM DTT, 0.1% NP-40, 10 mM MnCl2, 20 
µg/mL DNase I). They were subsequently incubated in the water bath for 30 minutes at 
37 °C and the tubes were regularly flicked during incubation to disperse precipitates. 
Protein concentrations were determined by Bradford assay (BioRad, cat. no. 500-0006) 




2.4.2. Whole-cell lysate 
Protein extracts were lysed in 6x laemmli buffer (50 mM Tris-HCl [pH 6.8], 10% 
Glycerol, 1% SDS, 100 mM DTT) and boiled at 95 °C for 5 minutes. A sample of each 
protein extract was prepared at 1µg/µl with 1x laemmli for immediate use and the 
corresponding sample with a higher concentration was stored at -20 °C. The whole-cell 
lysates were used for Western blot. 
 
2.4.3. Western blot 
Western blot was performed following standard procedures. Total protein extract or 
whole-cell lysate was prepared in 1x laemmli buffer, separated by SDS-PAGE and 
transferred to either nitrocellulose (NC) or polyvinylidene difluoride (PVDF) membranes. 
The blots were blocked in 5% milk in PBS for upwards of two hours and subsequently 
probed with primary antibodies (see primary antibody list), washed in PBS, followed by 
an incubation with a secondary antibody. The bound antibodies were detected using 
Immobilon Western chemiluminescent HRP substrate (Millipore, cat. no. WBKLS0500) 
using X-ray films or ChemiDoc (Bio-Rad) for visualization. Quantification of the signal 
was performed with Image Lab (BioRad) or with Image J for scanned films. Lamin B1 
was used as a loading control and for normalization of the detected signal. 
 
2.4.4. Stripping of Western blots 
This study used two methods of stripping. Generally, a technique of “gentle” stripping 
was employed using the Restore Plus Western Blot Stripping Buffer (Thermo Scientific, 
cat. no. 46430) following the manufacturer’s instructions. The success of this method was 
then tested by incubation with the respective secondary antibody and if the removal of 
the primary antibody was not successful with the commercial buffer, the membrane was 






Harsh stripping buffer (50 mL) 
Reagent Volume 
Tris HCl (pH 6.8, 1 M) 3.1 mL 
SDS 10% 10 mL 
MilliQ water 36.5 mL 
β-mercaptoethanol 450 µL 
 
 
2.5. RNA work 
 
2.5.1. Total RNA extraction 
Fresh cells growing in culture were lysed in an appropriate volume of TRIzol reagent 
(Invitrogen, cat. no. 15596018), for example a 6-well dish of both mouse ES cells and 
after 5 days of differentiation were lysed in 800-1000 µl TRIzol. Following the 
manufacturer’s instructions, total RNA was isolated from the TRIzol lysate. Chloroform 
was added to the lysate (0.2mL per 1 mL of TRIzol) and incubated at room temperature 
for 5 minutes and mixed thoroughly beforehand. The sample was subsequently separated 
by centrifugation (12,000 g, 15 min, 4 °C) into a lower red phenol-chloroform phase, an 
interphase, and a colourless upper aqueous phase. The aqueous phase contains the RNA 
and was cautiously transferred to a new tube. The rest was discarded. Glycogen (Thermo 
Scientific, cat. no. R0551) was employed for precipitation (0.5µl) and the RNA was 
precipitated by adding an equal volume of isopropanol to the aqueous phase, followed by 
10 minutes incubation at room temperature. The mix was centrifuged to pellet the 
precipitated RNA (12,000 g, 10 min, 4 °C). The supernatant was carefully decanted and 
the RNA pellet was washed twice in 75% ethanol. The pellet was left to air-dry and was 
then dissolved in nuclease-free water. 
 
2.5.2. RNA electrophoresis 
A bleach agarose gel was used to determine the integrity of the total RNA precipitated 
(Aranda et al., 2012). Ordinary household bleach was added to the standard 1% agarose 
suspension in 1x TAE (Tris-acetate-EDTA) buffer to a final concentration of 0.06% 
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sodium hypochlorite. The agarose-bleach suspension was incubated at room temperature 
for 5 minutes with occasional swirling before it was dissolved in a microwave oven. The 
RNA samples were diluted in standard DNA loading buffer and directly loaded unto the 
gel without pre-heating.  
2.5.3. DNase treatment 
DNase treatment was performed on RNA samples in order to remove contaminating DNA 
from the samples using the TURBO DNA-free kit (Ambion, cat. no. AM1907) and 
following the manufacturer’s instructions. RNA sample were usually diluted to 200 
ng/µL in 50 µL of 1x TURBO DNase buffer. 1 µL of the DNase was added to the RNA 
sample and the tube mixed gently. The digestion was incubated at 37 °C for 25 minutes 
in a PCR cycler. Afterwards, the enzyme was deactivated with DNase Inactivation 
Reagent (5 µL per 1 µL of DNase). The sample was inverted gently to mix and incubated 
at room temperature for 5 minutes, with occasional inverting. The DNase Inactivation 
Reagent was pelleted by centrifugation (1 minute on a mini centrifuge), and the 
supernatant containing RNA was transferred to a fresh tube. The obtained DNase-treated 
RNA was subsequently analysed by electrophoresis and NanoDrop. 
 
2.5.4. cDNA library synthesis 
Total RNA obtained from cells was reverse transcribed using SuperScript II Reverse 
Transcriptase (Invitrogen, cat. no. 18064014). Generally, a 20 µL reaction was performed 
for 800 ng of DNase-treated RNA. The reaction was set up in duplicate for each RNA 
sample, one for cDNA synthesis and one for the no reverse transcriptase control (NRT), 
which checks for DNA contamination. The RNA was diluted in nuclease-free water to a 
final volume of 8 µL. 1 µL of random hexamers (50 µM, Invitrogen, cat. no. N8080127), 
2 µL of dNTPs (5 mM each), 1 µL of nuclease-free water were added and mixed. The 
sample was heated to 65 °C for 5 minute and chilled on ice immediately after. After a 
brief centrifugation on the mini centrifuge, 4 µL of First-Strand Buffer (5×), 2 µL of DTT 
(0.1 M) and 1 µL of RNase Inhibitor (40 U/μL, Thermo Scientific, cat. no. EO0382) were 
added, mixed and incubated at 25 °C for 2 min. 1 µL (200 units) of the SuperScript II 
Reverse Transcriptase was added to each RNA sample (but not to their respective NRT 
controls). All sample were then incubated at 25 °C for 10 minutes, 42 °C for 50 minutes, 
and finally at 70 °C for 15 minutes. All samples and their NRT controls were diluted in 




2.5.5. Real-time qPCR for cDNA expression levels 
Real-time qPCR analysis for expression studies was performed using iTaq Univeral 
SYBR Green Supermix (BioRad cat. no. 1725124) in 10 µL reaction volume following 
the manufacturer’s instructions. The reaction mix contains 2 μL of the diluted cDNA (or 
NRT), 2 µL of primer mix (2.5 µM of each), 1 µL of water and 5 µL of the supermix 
(2×). The thermal cycling was consistently performed on a CFX96 Touch (Bio-rad). 
Initial denaturation and polymerase activation for 2 min at 95 °C, followed by 40 cycles 
of 5 sec at 95 °C and 30 sec at 60 °C. Real-time PCR primers used in this study are listed 
in Table 2.6.3. For primer sets that amplify repetitive targets, negative controls of NRT 
were included in parallel. The results were analysed using the CFX Manager Software 
(Bio-rad). 
 
2.6. Microscopic analysis 
 
2.6.1. Indirect immunofluorescence  
Mouse ES cells and mouse embryonic fibroblasts were grown with their respective 
culture medium on microscope slides (Thermo Scientific, cat. no. J1800AMNT) coated 
with 0.1% gelatine for upwards of 1.5 hours, except for MEFs, where the slides were used 
uncoated. The slides were placed in round tissue culture dishes in a tissue culture CO2 
incubator at 37 °C. After the cells attached to the slides the medium was removed by 
pouring PBS into the tissue culture dishes containing the slides. The slides were then 
transferred into Coplin jars and washed once in PBS. For immunostaining with anti-
FLAG antibody, cells were fixed in 4% formaldehyde in PBS at room temperature for 5 
minutes, followed by a brief wash in PBS. Cells were then permeabilized with 0.4% triton 
in PBS at room temperature for 15 minutes, followed by another wash in PBS. For 
staining with anti-SMARCAD1 antibody, cells were fixed in 4% formaldehyde in PBS 
for 10 minutes, permeabilized with 0.1% triton for 15 minutes, followed by another wash 
in PBS. Slides were then blocked in 10% filtered serum in PBS at 4 °C overnight. The 
primary antibody was diluted in the 10% serum blocking buffer and applied to the slides 
in a humidified chamber for one hour at room temperature. The slides were then washed 
three times in a Coplin jar with PBS for 5 minutes per wash in a shaker. The secondary 
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fluorochrome-coupled antibody was similarly diluted in 10% serum blocking buffer and 
applied to the cells for one hour at room temperature as indicated for the primary 
antibody. The three washing steps in PBS were repeated and the slides then mounted 
using Vectashield mounting medium containing DAPI (Vector Laboratories, cat. no. h-
1200). Slides were viewed using a Leica DMR fluorescence microscope, and images were 
collected using a QuantiFire XI digital microscope camera.  
 
2.6.2. GFP visualisation  
In order to visualise and monitor the GFP expression of transient transfections with GFP 
vectors or in inducible Smarcad1 knockdown cells for the induction of GFP-shRNA 
transcription, ES cells were grown on slides as described for immunofluorescence 
stainings. Cells were fixed with 2% formaldehyde for 5 minutes, permeabilized with 0.5% 
triton for 5 minutes, and mounted using Vectashield mounting medium containing DAPI. 
Slides were viewed as indicated for immunofluorescence. 
 
 
2.7. Key resource tables 
 
Antibody Antigen Source of 
Antibody 
Method 
IF ChIP Western 
SMARCAD1 
HPA016737 
Rabbit Sigma 1/80 3µg 1/1,000 
SMARCAD1 
PAB15737 
Rabbit Abnova  3µg 1/2,500 
SMARCAD1 
A301-593A 
Rabbit Bethyl  3µg 1/1,000 
SMARCAD1 
A301-592A 
Rabbit Bethyl  3µg  
SMARCAD1 
ab67548 
Rabbit Abcam  3µg  
SMARCAD1 
anti-CUE 
Rabbit Rowbotham et 
al. 2011 
1/400 3µL 1/5,000 
Lamin B1 
ab16048 
Rabbit Abcam   1/10,000 
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KAP1 ab22553 Mouse Abcam  3µg 1/10,000 
IgG kCH-504 
C15410206 
Rabbit Diagenode  3µg  
IgG I5381 Mouse Sigma  3µg  
FLAG F3165 Mouse Sigma   1/5,000 
FLAG F1804 Mouse Sigma 1/400 3µg 1/4,000 
V5 R960-25 Mouse Thermo Fisher 
Scientific 
  1/5,000 
H3 ab1791 Rabbit Abcam  3µg 1/10,000 
H3K9me3 
ab8898 
Rabbit Abcam  3µg  
H3K9me3 07-
523 
Rabbit Milipore   1/5,000 
H4K20me3 
9053 
Rabbit Abcam  3µg  
SETDB1  
11231-1-AP 
Rabbit Proteintech  3µg  
HDAC1 05-100 Mouse Millipore   1/2,500 
OCT4 sc-5279 Mouse Santa Cruz   1/1,000 
NANOG 
A300-397A 
Rabbit Bethyl   1/10,000 
G9a  
PP-A8620A-00 
Mouse R&D   1/2,000 
TFIIIC A301-
242A 
Rabbit Bethyl  3µg  
SUV39H1 8729 Rabbit Cell signaling   1/1,000 
SETDB1 sc-
66884 
Rabbit Santa Cruz   1/1,000 
H3.3 09-838 Rabbit Milipore  3µg 1/5,000 
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3.1. Identification and characterization of genome-wide SMARCAD1 
binding sites in mouse embryonic stem cells 
Closer inspection of the in vivo binding sites of SMARCAD1 genome-wide as well as its 
correlation with other epigenetic marks and chromatin regulators will give further insight 
into its function in ES cells. Remodellers generally do not directly bind DNA and as such 
are not trivial to ChIP. As no ChIP-validated antibody was available for SMARCAD1 the 
first step was to develop FLAG-ChIP-seq. Stable cell lines expressing 3xFLAG-
SMARCAD1 constructs were developed to investigate the genome-wide association of 
SMARCAD1 via ChIP-seq. The FLAG peaks were then used to develop a protocol for 
ChIP-seq with endogenous SMARCAD1. The SMARCAD1 constructs used, contain a 
5’-3xFLAG tag which has been successfully used for ChIP-seq (Gelbart et al., 2005; 
Volkel et al., 2015). Two distinct constructs were used; a FLAG-WT and a FLAG-
ATPase mutant construct of SMARCAD1. The mutation is well characterized and 
involves a single-nucleotide change (the substitution of a highly conserved arginine with 
lysine: K523R) within the ATPase domain of SMARCAD1 which abolishes the enzymes’ 
ability to hydrolyse ATP, resulting in a catalytically inactive mutant (Neves-Costa et al., 
2009; Richmond and Peterson, 1996; Rowbotham et al., 2011; Steglich et al., 2015). This 
catalytically inactive mutant has previously been used to study the function of ISW2, 
another ATP-dependent chromatin remodeller (Gelbart et al., 2005) where it was found 
to be a more sensitive ChIP reagent in marking its binding sites in vivo than its WT 
counterpart. It was proposed that the WT remodeller is recruited only transiently and only 
a basal interaction can be detected by ChIP when it “scans” the genome, whereas when 
the remodeller is no longer able to hydrolyse ATP it is possible to “capture” this transient 
interaction on chromatin via ChIP (Gelbart et al., 2005). Hence, to increase the probability 
to capture SMARCAD1 on chromatin, an ATPase mutant was to be used for FLAG-ChIP-
seq together with the WT. 
 
3.1.1. Establishment and characterization of FLAG-SMARCAD1 
stable ES cell lines 
Stable 3xFLAG-SMARCAD1 mouse ES cell lines were established for ChIP-seq. Two 
different constructs were transfected into PGK12.1 mES cells; 3xFLAG-SMARCAD1 
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WT and ATPase mutant (Figure 3.1.1a-b). The stable cell lines were sequenced to ensure 
the presence of the SMARCAD1 ATPase mutant and WT sequence (Figure 3.1.1b). 
 
Figure 3.1.1: Overview of the 3xFLAG-SMARCAD1 constructs, WT and ATPase mutant 
(a) depicts the two FLAG-constructs transfected into PGK12.1 mES cells. The upper cartoon 
shows the 3xFLAG-SMARCAD1 WT construct with its main domains and the lower one shows 
the ATPase mutant with the lysine to arginine substitution at amino acid 523. (b) DNA sequence 
of both cell lines by Sanger Sequencing. On the top the WT construct with the codon for lysine 
highlighted and on the bottom the ATPase mutant with a single base substitution resulting in a 
codon coding for arginine.  
 
The constructs were transfected into wild-type PGK12.1 mES cells and stable clones were 
selected, >50 WT SMARCAD1 expressing clones were obtained. In contrast, the 
transfection of the ATPase mutant resulted in a small number of colonies expressing the 
construct. Five stable clones of the ATPase mutant were obtained from two separate 
transfections. The WT clone with the lowest overexpression was selected in order to 
minimise potential off-target effects caused by substantial overexpression, plus to 
maintain comparable levels to the ATPase mutant which are expressed at much lower 
levels (Figure 3.1.2a). The highest expressing ATPase mutant clone (mt8) was selected. 
A mix of expression levels was observed by IF in the cell line, hence an attempt was made 
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to clone out the highest expressing cells. For this, cells were cloned out using 96 well 
plates and LiCor quantification and the resulting clone is marked as mt8c in Figure 3.1.2a. 
However, it showed no improved expression levels compared to the initial clone (Figure 
3.1.2a, lane 6). Similarly, the transient transfection of 3xFLAG-SMARCAD1 WT and 
ATPase mutant constructs on top of the stable cell lines expressing the construct did not 
improve the level of 3xFLAG-SMARCAD1 ATPase mutant expression, whereas WT 
expression increased (Figure 3.1.2b). To rule out poor sample quality the vectors were 
repeatedly phenol-chloroform extracted and Nanodrop measurements indicated very pure 
DNA. It was hypothesized that the ATPase mutant has a dominant negative effect and its 
expression is silenced. However, a different stable ATPase mutant cell line (with a single 
FLAG tag) was established simultaneously by the same experimenter for a colleague and 
in the same cells, and showed similar expression to its WT construct. Additionally, 
another stable ATPase mutant cell line in different cells (E14) was successfully 
established by colleagues in the lab. 
 
Figure 3.1.2: Expression analysis of FLAG-SMARCAD1 (WT and ATPase mutant) in stable 
ES cell clones.  
(a) Expression analysis of SMARCAD1 by Western blot comparing a 3xFLAG-SMARCAD1 
expressing cell line (WT; lane 2 & 3) compared to all 6 clones of the 3xFLAG-SMARCAD1 
ATPase mutant. Shown as a control; a pool expressing the empty vector backbone (lane 1&10). 
(b) Western blot depicting the stable cell lines selected (WT; lane 1 & 2, and mt; lane 3), before 
and 2 days after the transient transfection of the corresponding vectors on top of the stable 




The stable 3xFLAG-SMARCAD1 WT cell line depicted in Figure 3.1.2 was selected for 
further experiments together with the 3xFLAG empty vector pool as a control. The 
catalytically inactive mutant was not included in the further analysis due to the problems 
encountered when trying to establish a stably expressing cell line. At a later stage in this 
study an ATPase mutant in a different ES cell line (E14) is employed. 
The pluripotency of the WT cell line is not affected by the expression of the construct as 
shown by the pluripotency marker Nanog and neither is the expression of the 
transcriptional regulator KAP1, the stoichiometric binding partner of SMARCAD1 
(Figure 3.1.3a). In addition, the SMARCAD1 WT construct localizes similar to the 
endogenous SMARCAD1 protein; to the nucleus of mES cells overall and with distinct 
enrichment at DAPI-dense loci (Figure 3.1.3b) which represent the heterochromatin of 
mouse ES cells. Taken together, this illustrates that the tagged overexpressed protein is a 
good proxy for the native one. The stable 3xFLAG-SMARCAD1 WT cell line was 
selected for ChIP-seq together with the 3xFLAG empty vector pool as a control. 
 
Figure 3.1.3: The 3xFLAG-WT protein behaves like the endogenous SMARCAD1 protein. 
(a) Western blot analysis showing PGK12.1 mES cells stably expressing 3xFLAG-SMARCAD1 
protein. The level of SMARCAD1 and FLAG-protein expression is shown in two different 
dilutions. Pluripotency is not affected as shown by NANOG. Shown as a control; a pool 
expressing the empty vector. Lamin B1 is shown as a loading control. 2µg and 4µg from total 
protein extracts from PGK12.1 mES cells. (b) Indirect Immunofluorescence of the 3xFLAG-
SMARCAD1 protein and endogenous SMARCAD1 in PGK12.1 mES cells. Soluble proteins 
were extracted with detergent prior to fixation. Endogenous SMARCAD1 localizes to pericentric 




3.1.2. Validation of identified FLAG-SMARCAD1 binding sites 
The FLAG-ChIP-seq resulted in 3317 detected binding sites after filtering. The results of 
the FLAG-ChIP-seq will be discussed in more detail later. The focus in this section is on 
how selected binding sites were validated by ChIP-qPCR and the information used to test 
antibodies against the endogenous, untagged protein. The obtained peaks were used to 
optimize the ChIP-seq protocol for pull-down with an antibody against the endogenous 
SMARCAD1 protein since the antibodies against SMARCAD1 available at this time 
point had not been validated for ChIP. The top 100 FLAG-SMARCAD1 peaks were 
investigated manually (representative screenshot shown in Figure 3.1.4a, left panel) and 
five peaks were selected for primer walking by ChIP-qPCR (representative example: Fig. 
Figure 3.1.4a, right panel). FLAG-SMARCAD1 enrichment was confirmed to be 
restricted to the peak and progressively lost with primers lying progressively further away 
from the SMARCAD1 peak. 
 
Figure 3.1.4: 3xFLAG-SMARCAD1 is enriched at defined binding sites in mouse ES cells. 
Left panel: example of a genome browser screenshot of a FLAG ChIP-seq peak over the Ezr gene 
in PGK12.1 3xFLAG SMARCAD1 mES cells. 3xFLAG empty vector ChIP-seq shown as 
control. Genomic location is indicated. Underneath three primer pairs are displayed used for 
primer walking as depicted in the right panel with ChIP-qPCR with a FLAG antibody. Enrichment 
is shown as percent input (+/-SE). 
 
Five antibodies against the endogenous SMARCAD1 protein were selected for ChIP 
validation. They were tested extensively by the Mermoud lab for specificity in IF and 
Western blot and all antibodies were specific for SMARCAD1, detecting no signal in the 
knockdown. Subsequently, two FLAG-SMARCAD1 binding sites were selected to test 
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the antibodies by ChIP-qPCR in SMARCAD1 knockdown and control mouse ES cells. 
The binding sites were validated with five SMARCAD1 antibodies and shown to be 
specific for endogenous SMARCAD1 binding (Ezr and Srrm2 shown in Figure 3.1.5a, 
b). Three antibodies were selected for further optimization by double-crosslinking in a 
different ES cell line in order to improve the levels of bound protein to chromatin, since 
remodellers traditionally do not bind DNA directly. Double-crosslinking is an efficient 
“two-step” ChIP method that involves the fixation of protein-protein interactions 
followed by protein-DNA fixation with formaldehyde as described in the standard 
method. For protein-protein crosslinking NHS-ester crosslinking agents are used, such as 
DSG, which results in irreversible covalent amide bonds (Tian et al., 2012). Two 
antibodies showed robust enrichment using double-crosslinked compared to single-
crosslinked cells (Figure 3.1.5c). In addition, the enrichment was specific to the 





Figure 3.1.5: SMARCAD1 ChIP-qPCR detects specific peaks and can be optimized by 
double-crosslinking. 
(a) & (b) ChIP-qPCR on a candidate locus is depicted (Ezr & Srrm2) with five different SMARCAD1 
antibodies (left to right: A301-593A, A301-592A, Anti-CUE, ab67548, PAB15737) in single-
crosslinked chromatin from PGK12.1 SMARCAD1 knockdown and Control mES cells. The primers 
are as shown in Figure 3.1.4. Enrichment is shown as percent input +/-SE. (c) FA-DSG crosslinking 
leads to a robust enrichment of SMARCAD1 binding. Exemplary ChIP-qPCR with three antibodies 
against SMARCAD1 in FA-crosslinked chromatin as well as in DSG-FA-crosslinked chromatin (E14 
mES cells Antibodies from left to right: A301-592A, PAB15737 and HPA016737. P3 is shown as a 





Endogenous ChIP-seq was performed with the PAB15737 antibody and double-
crosslinked chromatin in PGK12.1 control and SMARCAD mES knockdown cells. This 
SMARCAD1 knockdown cell line has been well characterised by Jacqueline Mermoud 
and the results have been published in (Sachs et al., 2019).  
 
3.1.3. Genome-wide binding sites of SMARCAD1 in mouse ES cells 
In addition to FLAG and SMARCAD1 ChIP-seq, H3K9me3 ChIP-seq was performed in 
the same mES cell line (PGK12.1) to determine its overlap with SMARCAD1 binding 
sites. To determine the high affinity binding sites of SMARCAD1 in mES cells, peaks 
occurring in both the FLAG-ChIP-seq as well as in the endogenous ChIP-seq were used. 
It was, however, determined beforehand that they are of similar high quality (Table 3.1.1). 
The bioinformatic analysis was performed in collaboration with bioinformaticians 
Andrea Nist and Boris Lamp, who performed the sequencing, the read alignment and the 
peak calling. The figures rendered by Boris Lamp are designated as such. 
The number of effective reads sequenced is similar between the SMARCAD1 ChIP-seqs 
as well as in the backgrounds used, meaning all libraries were sequenced at comparable 
depth. The number of unfiltered and filtered peaks is also indicated. The endogenous and 
FLAG-ChIP-seq detect a similar number of filtered SMARCAD1 binding sites (5727 and 












PGK12.1 PGK12.1 PGK12.1 PGK12.1 
    
Cross-linking double Double double Double 
ChIP antibody SMARCAD1 SMARCAD1 FLAG H3K9me3 
Effective 
reads 
7.93E+07 6.52E+07 5.05E+07 5.47E+07 
Used 
background 
IgG WT IgG KD FLAG Ab IgG WT 






6.71E+07 6.44E+07 4.66E+07 6.71E+07 
7.96E+07 6.37E+07 6.22E+07 7.96E+07 
Peak caller MACS MACS MACS SICER 
unfiltered 
peaks 
15418 287 8786 55183 
filtered peaks  5727 63 3317 10849 
Table 3.1.1. Summary of ChIP-seqs in PGK12.1 mES cells 
FLAG-SMARCAD1 and endogenous SMARCAD1 ChIP-seq in mES cells summarising the type 
of crosslinking, the antibodies used. 
 
The tagged-SMARCAD1 and endogenous ChIP-seq were investigated for the genomic 
distribution of SMARCAD1. 2380 peaks were found in both datasets (Figure 3.1.6c). 
These “high confidence” peaks were selected for further analysis. Their genomic 
distribution was analysed and it was found that they lie predominantly at intergenic sites 
in the mouse genome (Figure 3.1.6a). They are found at other interesting sites, such as 
promoters, and this will be discussed in more detail later. Most importantly, the 
SMARCAD1 binding sites identified, designate specific peaks since they disappear in the 






Figure 3.1.6: FLAG-SMARCAD1 and endogenous SMARCAD1 ChIP-seq identifies 
predominantly overlapping binding sites. 
(a) Genomic distribution of SMARCAD1 (S) compared to the distribution of elements in the 
mouse genome (G). The numbers depict percentages. SMARCAD1 predominantly binds 
intergenic regions. SMARCAD1 genomic distribution compared to the distribution of elements 
in the murine genome. The largest proportion (72%) of SMARCAD1 binding sites lie at intergenic 
sites followed by intronic regions (21%). (b) Cumulative plot of all called SMARCAD1 peaks in 
mES cells and SMARCAD1 knockdown cells showing the specificity of SMARCAD1 binding 
sites. (c) Venn diagram depicting the 5669 peaks detected in the endogenous SMARCAD1 ChIP-
seq after filtering, of which 2380 are also present in the FLAG-SMARCAD1 ChIP-seq (from a 
total of 3247 peaks). The genomic distribution, cumulative plot, and Venn diagram were 
generated in collaboration with Boris Lamp and Philipp Bergmaier.  
 
The ChIP-seq of the WT construct and the endogenous SMARCAD1 protein share a large 
number of peaks. However, the fact remains that the endogenous ChIP detected more 
peaks than the FLAG ChIP-seq and a substantial number of peaks do not overlap. If these 
peaks are investigated manually however, it becomes clear that the endogenous peaks do 
also display FLAG enrichment, but at a level underneath the assigned peak threshold. 
Therefore, it must be concluded that the FLAG-ChIP is generally less sensitive but the 
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actual overlap is potentially much larger than observed, and the two methods do not detect 
different binding sites. 
 
3.1.4. SMARCAD1 binding sites are associated with 
heterochromatic factors and modifications 
To determine the role of SMARCAD1 in ES cells the overlapping peaks from the FLAG-
SMARCAD1 and endogenous SMARCAD1 ChIP-seq, considered high-confidence 
peaks, were investigated for distinct chromatin features. Primarily, the overlap with the 
H3K9me3 ChIP-seq from this study, and a published KAP1 (Elsasser et al., 2015) dataset 
was determined. Published datasets of other heterochromatic factors and modifications 
were also included (Figure 3.1.7). SMARCAD1 binding sites are predominantly 
associated with specific repressive histone marks genome-wide, such as H3K9me3 (our 
dataset) and H4K20me3 (Mikkelsen et al., 2007). They are not linked with regions 
containing the polycomb-associated repressive mark H3K27me3 nor with sites of active 
chromatin denoted by histone marks such as H3K27ac or H3K4me3. SMARCAD1 
binding sites also overlap with the transcriptional regulator KAP1, and SETDB1, a 
histone methyltransferase, as well as the histone variant H3.3. Other histone 
methyltransferases are not enriched in these regions (G9a, Suv39h1 and Suv39h2). Indeed 
85.5% of SMARCAD1 sites overlap with H3K9me3 and 87.5% with KAP1 binding sites 
(Figure 3.1.7b), (KAP1 dataset:  (Elsasser et al., 2015). Altogether, the vast majority of 
high-confidence SMARCAD1 sites are associated with both H3K9me3 and KAP1 (82%) 
(Figure 3.1.7c). The overlap of SMARCAD1 sites with H3K9me3 might indicate a role 
in constitutive heterochromatin. Whereas H3K9me3 is important for many types of 
constitutive heterochromatin, the presence of H4K20me3, KAP1 and SETDB1 is 




Figure 3.1.7: SMARCAD1 binds heterochromatic regions together with ERV regulators. 
(a) heatmaps made by Boris Lamp of high-confidence SMARCAD1 peaks (intersections of 
endogenous and FLAG-SMARCAD1) and SMARCAD1 knockdown showing the specificity of 
SMARCAD1 binding sites. Also shown is the association of SMARCAD1 with the histone marks 
H3K9me3 (this study) and H3K20me3, the histone variant H3.3, and the ERV regulators KAP1 and 
SETDB1. Genomic scale depicted on the bottom of the heatmaps. b) and c) Venn diagrams made by 
Philipp Bergmaier showing the overall shared sites between SMARCAD and H3K9me (1884) and 
between SMARCAD1 and KAP1 (2289). Also shown are the sites shared between both KAP1 and 
H3K9me3, which make out the vast majority of all SMARCAD1 sites (82%). Intersection of FLAG 
and SMARCAD1; 2196 peaks) with the H3K9me3 profile (10803 peaks; this study) and KAP1 
binding sites; 11635 peaks (Elsasser et al., 2015). Publicly available external ChIP-Seq data were 
obtained from GEO using the following accession numbers: GSM1555120 (KAP1), GSM1429923 
(KAP1 input), GSM307622 (H4K20me3), GSM1033638 (H3K27me3), GSM594578 (H3K27ac), 
GSM1033636 (H3K4me3), GSM1555116 (H3.3), GSM459273 (SETDB1), GSM1215219 (G9a), 




SMARCAD1 binding sites in mES cells were determined in two biological replicates. 
The shared peaks of the two ChIPs are predominantly localized to intergenic sites but 
contain a number of interesting peaks at other regions, such as at transcriptional start sites 
of promoters of imprinted genes, which will be investigated in the next chapters. The 
binding sites generally fall into two categories, single-copy genes and repetitive elements. 
During the course of this study another SMARCAD1 ChIP-seq was published (Xiao et 
al., 2017). Single-crosslinking was employed by Xiao et al, and consequently, a 
significantly lower number of peaks was detected compared to the endogenous ChIP-seq 
discussed in this study (525 compared to 5727 peaks, respectively). Additionally, the 
knockdown cell line used was sequenced at considerably more depth than the control 
(8,19E+07 and 1,30E+07 effective reads, respectively) which gives rise to a large number 
of unspecific peaks in the knockdown. Overall, the coverage is low, hence, the ChIP-seq 
discussed in this study adds valuable information to the pursuit of defining the binding 
sites of remodellers in ES cells.  
 
3.1.5. Loss of SMARCAD1 impacts ESC morphology and 
pluripotency  
This study will employ a loss-of-function approach to determine the role of SMARCAD1 
on its binding sites. The effect of SMARCAD1 knockdown in ES cells has been 
characterised by Jacqueline Mermoud and Xiao et al., (Sachs et al., 2019; Xiao et al., 
2017). For the purpose of this study the effects on morphology and pluripotency of 
SMARCAD1 removal were investigated. Additionally, the global expression level of 
several chromatin modifiers as well as histone modifications were examined as their 
binding is studied on a local level subsequently.  
SMARCAD1 knockdown affects the morphology of ES cells and their proliferation rate 
in addition of affecting the expression of distinct pluripotency markers (Sachs et al., 2019; 
Xiao et al., 2017). To confirm this in a distinct cell line from the PGK12.1 SMARCAD1 
knockdown line characterised by Jacqueline Mermoud, this cell line in addition to an E14 
SMARCAD knockdown cell line were grown three days in 96-well plates. Pictures were 
taken every three hours and the changes in their morphology quantified. Representative 
screenshots are shown in Figure 3.1.8a. Initially after plating, both control and 
knockdown cells show high eccentricity, however over time the control cells form 
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characteristic spherical ES cell colonies whereas the knockdown cells form flat, irregular 
colonies, similar to differentiated cells (Figure 3.1.8b).  
 
Figure 3.1.8: Upon the knockdown of SMARCAD1 mouse ES cells lose their spherical 
morphology. 
(a) Depicted are snapshots at different time points during the growth of control and stable 
SMARCAD1 knockdown stem cells (E14) plated simultaneously at the same densities. (b) shown 
is the corresponding analysis of cell morphology at 3-hour intervals (depicted in average 
eccentricity) measured in real time with and IncuCyte for three days. PGK12.1 ESCs stably 
expressing an shRNA targeting Exon 7 and E14 ESCs stably expressing an shRNA targeting the 
3'UTR of Smarcad1 and appropriate control knockdown cells were plated at six different 
concentrations ranging from 10 K to 312 cells/ 96 well (n=3). A representative example is shown, 
the error bars depicting the S.D. from triplicates. 
 
3.1.6. The global protein levels of heterochromatin factors are not 
affected by loss of SMARCAD1 
The stable PGK12.1 SMARCAD1 knockdown clone used for endogenous ChIP-seq 
displays almost complete removal of SMARCAD1 protein levels observed in both 
Western blot and immunofluorescence (Figure 3.1.9). The pluripotency marker NANOG 
is reduced in the knockdown, as seen in previous experiments by Jacqueline Mermoud 
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and Dong Ding. However, proteins and enzymes important for heterochromatin 
regulation are globally unaffected (Figure 3.1.9a). Of note, the hallmark of constitutive 
heterochromatin, H3K9me3, is unaffected as are KAP1 and the histone methyltransferase 
SETB1/ESET which play important roles in H3K9me3 deposition over endogenous 
retroviral elements (ERVs). Other histone methyltransferases involved in H3K9me3 
deposition over other regions are similarly unaffected (G9a & Suv39h1) and the histone 
deacetylase HDAC1 is also globally unchanged (Figure 3.1.9a).  
 
Figure 3.1.9: The stable knockdown of SMARCAD1 in mES cells does not affect the global 
expression of H3K9me3 and specific histone methyltransferases and deacetylases. 
(a) Western blot of stable SMARCAD1 knockdown in PGK12.1 mES cells. Global levels of 
H3K9me3 are shown, as well as levels of the histone methyltransferases SETDB1, G9a and 
Suva39. Also shown are the global levels of histone deacetylase I and KAP1. H3 and Lamin B1 
are shown as loading controls. (b) Immunofluorescence in PGK12.1 SMARCAD1 knockdown 




3.2. SMARCAD1 is recruited to KAP1 targets by its CUE1 domain 
SMARCAD1 interacts with several factors that play roles in repression, most notably the 
stoichiometric interaction partner of SMARCAD1 in both somatic and ES cells is KRAB-
associated protein 1, KAP1 (TRIM28; TIF1β) (Ding et al., 2018). Additionally, several 
KRAB-ZFPs are found in the proteomic interactome of SMARCAD1 (Mermoud lab, 
unpublished).  
 
3.2.1. SMARCAD1 binding sites fall into distinct categories 
 
Figure 3.2.1: Types of SMARCAD1 binding sites in mouse embryonic stem cells. 
Overview illustrating the different regions bound by SMARCAD1 in mouse ES cells. 
 
SMARCAD1 peaks in mouse embryonic stem cells fall both within repetitive regions and 
on single-copy genes (Figure 3.2.1). The following examples have all been confirmed by 
ChIP-qPCR in two mES cell lines and the corresponding SMARCAD1 knockdown 
(depicted in Figure 3.2.2, Figure 3.2.3, and Figure 3.2.5). Among the single-copy genes 
were several interesting sites; the promoters bound by SMARCAD1 were often those of 
imprinted genes (Fkbp6, Peg3, and Peg13 (Figure 3.2.2a, left panel). Also bound by 
SMARCAD1 are the two regulatory promoters of the non-coding gene Xist which is 
necessary for X-inactivation (Figure 3.2.2a, right panel). SMARCAD1 was also found to 
bind the 3’end of genes coding for KRAB-ZFPs (Figure 3.2.2a, left panel). Other single-
copy genes were found to be highly bound by SMARCAD1 not on their promoters, but 




Figure 3.2.2: SMARCAD1 binds single-copy genes and repetitive elements. 
(a) Left panel: ChIP-qPCR of SMARCAD1 in E14 control and two-day transient knockdown mES 
cells. Shown are different examples of single-copy genes bound by SMARCAD1, among them 
imprinted genes (Fkbp6, Peg13 and Peg3), KRAB-Zinc Finger Protein genes (Zfp629 and Zfp13). 
Right Panel: ChIP-qPCR of SMARCAD1 in PGK12.1 stable control and knockdown XX mES cells 
over the two promoters of the Xist gene. Depicted is one representative of two biological replicates 
(n=2). Enrichment is shown as percent input (+/-SE). (b) SMARCAD1 and KAP1 binding to major 
and minor satellites (left panels) or telomeres (right panels) in E14 control and two-day transient 
SMARCAD1 knockdown and in PGK12.1 stable control and SMARCAD1 knockdown mES cells. 
Depicted is the mean ± S.E. from three biological replicates (n=3) shown as percent input. P values 
are from paired two-tailed Student’s t-test: *p < 0.05. 
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Repetitive regions are characteristic of constitutive heterochromatin. Among these 
SMARCAD1 binds telomeres (Figure 3.2.2, upper and lower right panels), major and 
minor satellites, which make up the centric heterochromatin in the mouse (Figure 3.2.2, 
upper and lower left panels), and transposons (see next section 3.2.2.).  
KAP1 is a stochiometric component of SMARCAD1 complexes, and indeed directly 
interacts with SMARCAD1 in vitro (Ding et al., 2018). Hence, it was tested whether these 
proteins co-localize in chromatin. Most of the focus of this study will be on the role of 
SMARCAD1 on transposons, including the stable association of KAP1 on these 
elements. However, other sites were briefly investigated; KAP1 was found enriched on 
satellites and telomeres. SMARCAD1 likely plays varying roles on its binding sites and 
as a first step, it was addressed whether KAP1 binding is affected upon SMARCAD1 loss 
on different sites. For KAP1 binding on telomeres and major and minor satellites 
SMARCAD1 appears to play a minor role: in the stable SMARCAD1 knockdown cell 
line (PGK12.1) KAP1 binding is clearly unaffected in the knockdown (Figure 3.2.2b, 
upper panels). The E14 cells contain an induced SMARCAD1 knockdown, here shown 
after two days of SMARCAD1 removal. KAP1 is not significantly affected but it appears 
somewhat reduced compared to the stable cell line (Figure 3.2.2b, lower panels), implying 
that SMARCAD1 might play a minor role in KAP1 recruitment or maintenance on these 
sites probably concurrent with other factors since KAP1 is successfully maintained in a 
stable cell line, but an immediate effect can be observed in a transient SMARCAD1 
knockdown. In conclusion, on major and minor satellites, and on telomeric regions KAP1 
association to chromatin is generally stable irrespective of SMARCAD1 binding.  
 
3.2.2. SMARCAD1 binds class I and II ERVs in mES cells 
Genome-wide SMARCAD1 is associated with the transcriptional regulator KAP1, 
H3K9me3, the hallmark of constitutive heterochromatin, as well as H4K20me3 (Figure 
3.1.7). These two histone marks are involved in the silencing of ERVs (Matsui et al., 
2010; Rebollo et al., 2011). Not only that, but SMARCAD1 also overlaps with SETDB1 
binding sites but not with any of the other histone methyltransferases. SETDB1 catalyses 
the deposition of H3K9me3 on ERVs (Matsui et al., 2010) and is recruited by KAP1 
(Cheng et al., 2014b; Frietze et al., 2010; Iyengar and Farnham, 2011; Schultz et al., 
2002). Additionally, the histone variant H3.3 is present on ERVs that are bound by 
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SMARCAD1. This variant has previously been linked to the silencing of ERVs, 
particularly IAPs (Elsasser et al., 2015).  
Taken together the data point to a potential role of SMARCAD1 on ERVs and thus they 
were investigated as potential targets for the remodeller SMARCAD1. SMARCAD1 
binding was plotted to the murine database of repetitive elements by Boris Lamp, and in 
an unbiased approach the elements with the highest SMARCAD1 binding were analysed, 
as well as their subcategories.  It was discovered that SMARCAD1 peaks are enriched at 
Intracisternal A-type particles (IAPs), a category of class II ERVs which are active in the 
mouse (Gerdes et al., 2016; Qin et al., 2010), (Figure 3.2.3). Similarly, H3K9me3 (this 
study) and KAP1 (Elsasser et al., 2015) are enriched at IAPs in the mouse, mimicking the 
distribution of SMARCAD1 (Figure 3.2.3) SMARCAD1 is also enriched on VL30 
elements, a class I ERV family. The same binding pattern of SMARCAD1 observed in 
ChIP-seq can be seen in the ChIP-qPCR data. Notably in the ChIP-seq, SMARCAD1 is 
not enriched over internal sequences of VL30 elements, (annotated as int, Figure 3.2.3), 
but can be detected when VL30 elements are plotted as a whole. This is reflected in the 
qPCR data, where the VL30 primer recognizes the primer binding site within the 5’UTR 
region, and SMARCAD1 enrichment can be observed. Importantly, both methods are 
“genome-wide” for repeats, as the ChIP-qPCR uses consensus primers. SMARCAD1 
binding is also detected over the class II elements ERVK10C and MusD/ETn, while it is 
not bound to the class III element MuERVL (Figure 3.2.3a).  
The non-LTR retrotransposon LINE was not found to be enriched for SMARCAD1 
binding. Importantly, this element possesses a very high copy number in the mouse 
genome (around 600,000 copies, (Wang, 2017)), and yet no SMARCAD1 binding was 
found, illustrating that the enrichment over IAP elements is not due to their high copy 
number and is indeed specific. Additionally, the LINE element L1Md_F was investigated 
for SMARCAD1 binding. L1Md_F is a distinct L1 lineage that appears in the mouse 
genome around 4.35 million years ago (Castro-Diaz et al., 2014). In contrast to other L1 
elements which do not generally require KAP1 for their repression, L1Md_F has been 
shown to be repressed by KAP1 and KRAB-ZFP mechanisms in both human and mouse 
ES cells, giving rise to the model that newly emerging L1 lineages are first suppressed by 
DNA-methylation mechanisms before specific KAP1-recruiting ZFPs are selected 
(Castro-Diaz et al., 2014). However, no SMARCAD1 binding was detected on LINE1 
elements, including L1Md_F in PGK12.1 mouse ES cells by ChIP-seq and ChIP-qPCR 
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(Figure 3.2.3). KAP1 binding, while above an intergenic control site (background), is still 
relatively low. Nonetheless, H3K9me3 is clearly enriched on L1Md_F elements 
compared to other LINE1 sites. This suggests that SMARCAD1 does not play a role in 
LINE1 repression, however it might be worth to investigate L1Md_F in other cell lines, 
since KAP1 binding is also relatively low in PGK12.1 mES cells.  
 
Figure 3.2.3: SMARCAD1 binds lass I & II ERV elements together with KAP1 and 
H3K9me3. 
(a) Combined box- and jitterplot depicting the binding of SMARCAD1 (top, this study), 
H3K9me3 (middle, this study) and KAP1 (bottom, (Elsasser et al., 2015)) as log2 fold over input 
over different types of class I, II and III ERV elements as well as non-LTR retrotransposons 
(LINEs) in PGK12.1 mES cells. Each grey dot represents a single element. Repeat families shown 
are characterized according to the UCSC RepeatMasker annotation. “int” represents an internal 
ERV element. General annotations such as “IAP” or “ERVK10C” denote all elements of that 
type. IAPA_MM-int, IAPEz-int and IAPLTR1a are the most enriched elements, followed by “IAP 
other” which represents all other IAP elements. (b) Representative ChIP-qPCR of three biological 
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replicates of SMARCAD1, H3K9me3 and KAP1 over class I, II and III ERV elements as well as 
non-LTR retrotransposons in PGK12.1 mES cells. This dataset is used again in Figure 3.3.1 for 
SMARCAD1 and KAP1 and Figure 3.3.2 for H3K9me3 as one of three biological replicates. All 
repeat annotations denote consensus primers for all elements of that category except IAPs which 
represents a specific IAP element within the Mier3 gene (IAPc represents the consensus primer). 
Also shown is a subclass of LINE elements, L1Md_F, where high KAP1 binding was reported 
(Castro-Diaz et al., 2014). An intergenic single-copy site is shown as control. Enrichment is 
shown as percent input (+/- SE).  
 
SMARCAD1, KAP1 and H3K9me3 enrichment overlap in their peak distribution as 
shown here in exemplary screenshots on two examples: IAPEz-int element within an exon 
of the Mier3 gene (Figure 3.2.4a) and on an IAP element within the Prnp gene (Figure 
3.2.4b). Regions bound by SMARCAD1 are very broad in general, almost 20kb is some 
cases, which is very distinct from the precise peaks found in transcription factors, and 
more characteristic of histone marks. The IAP element within the Mier3 gene is flanked 
by its LTRs, whereas the one within the Prnp gene denotes a truncated version of an IAP 
element. The element is next to an MERVL element, noticeably with no SMARCAD1, 
KAP1 or H3K9me3 enrichment (Figure 3.2.4b). 
 
Figure 3.2.4: SMARCAD1, KAP1 and H3K9me3 bind large regions containing repetitive 
elements. 
Screenshots depicting SMARCAD1, KAP1 and H3K9me3 called peaks in the IGV Genome Browser 
over IAP elements. (a) displays an element of the subcategory IAPEz flanked by its LTR domains, 
within an exon of the Mier3 gene. (b) displays and IAP element within the Prnp gene. On the right it 
has its LTR domain and on the left, it is truncated by an MERVL element, a class III ERV. 




A challenge in the repeat field is to identify individual copies. To overcome this, primers 
for ChIP-qPCR were designed and tested to identify SMARCAD1 binding. Primers were 
devised to lie just a few nucleotides outside an IAP element, thus denoting a single, 
specific binding event, here shown for the SMARCAD1 peak within the Mier3 gene 
(Figure 3.2.5a). The other primers employed are consensus primers encompassing either 
all IAP elements (IAP primer), or a subset (IAPEz, IAP1). IAPEz is the most abundant 
subcategory of IAPs found within or near genes in the mouse exhibiting approximately 
200 insertions, predominantly intronic (Maksakova et al., 2006). SMARCAD1 (this 
work) and KAP1 (Elsasser et al., 2015) are both enriched over IAPEz elements (Figure 
3.2.5a).   IAP1 is the most recent IAP element that has emerged in the murine genome 
and in neuronal progenitor cells its expression is deregulated upon the loss of KAP1 
(Fasching et al., 2015). In mES cells however, it shows no SMARCAD1 or KAP1 
enrichment (Figure 3.2.5a), showcasing an example of tissue-specific IAP regulation. It 
was previously suggested that IAPs take on specific regulatory roles later in development 
and require distinct regulatory processes for certain subcategories.  
ERVs in general are genomic elements that structurally retain their resemblance to 
retroviruses, but their structure is rarely completely intact, most ERVs are truncated and 
the env gene is very frequently lost. Solitary LTRs are also quite common (Cohen et al., 
2009; Goke and Ng, 2016; Kassiotis, 2014). With consensus primers for distinct structural 
elements of IAPs it is possible to determine the distribution of SMARCAD1 over IAPs 
genome-wide in mouse ES cells. Figure 3.2.5b reveals that the highest SMARCAD1 
enrichment is found at the 5’UTR followed by the gag gene; a distribution also exhibited 





Figure 3.2.5: SMARCAD1 and KAP1 bind distinct IAP subcategories and show a similar 
enrichment pattern over IAP elements. 
(a) ChIP-qPCR in E14 mES cells of SMARCAD1 and KAP1 over different IAP families, a 
specific IAP element within the Mier3 gene, all IAP elements, the subcategory IAPEz, the gag 
sequence within IAPEz elements as well as the young IAP element IAP1pol. Enrichment is shown 
as percent input (+/-SE). (b) Top: IAP structure depicting the primers used in the ChIP-qPCR. 
Bottom: ChIP-qPCR in E14 mES cells showing SMARCAD1 and KAP1 distribution over IAP 
elements genome-wide. Enrichment is shown as percent input (+/-SE). 
 
3.2.3. SMARCAD1 and KAP1 are co-enriched at all tested 
SMARCAD1 binding sites in mESCs 
The data obtained in this study illustrate that SMARCAD1 and KAP1 share target sites. 
Among them imprinted genes, KRAB-ZFP genes, satellites, telomeres and class I and II 
ERV elements. It is not known whether they occupy their shared targets simultaneously 
or independently. To address this, sequential ChIP on representative binding sites was 
performed from both directions; a SMARCAD1 ChIP followed by KAP1 and vice versa 
(Figure 3.2.6). The results reveal that the two proteins do indeed co-occupy the 5 tested 
sites of SMARCAD1-bound elements; promoters of imprinted genes, the 3’end of ZFPs, 
Ezr, and retrotransposons (Figure 3.2.6). This strongly suggests a functional link between 




Figure 3.2.6: SMARCAD1 and KAP1 co-occupy exemplary SMARCAD1 binding sites. 
Depicted is sequential ChIP to illustrate the co-occupancy of SMARCAD1 and KAP1 (a) within 
a single-copy gene, (b) on the promoter of an imprinted gene and (c) on the 3’ end of a KRAB- 
Zinc Finger gene, (d) a consensus IAP element, (e) a specific IAP element and (f) an intergenic 
site is shown as negative control. The first ChIP is indicated on the top of each panel, followed 
by the re-ChIP annotated underneath. IgG is used as a control for both steps. Enrichment is shown 




3.2.4. SMARCAD1 is recruited to chromatin via its CUE1 domain-
mediated interaction with KAP1 
SMARCAD1 binding sites are co-enriched with KAP1 (Figure 3.1.7 and Figure 3.2.6), 
both for single-copy genes and repetitive regions. To investigate the order of recruitment 
to chromatin the strategy was to investigate the binding of SMARCAD1 and KAP1 to 
chromatin in the absence of their respective partner protein. The effect of the 
SMARCAD1 knockdown is discussed in chapter 3.3.1. 
Initially a transient KAP1 knockdown was performed to determine whether SMARCAD1 
association to chromatin is dependent on the presence of KAP1. KAP1 protein levels 
were successfully reduced (Figure 3.2.7). However, this was accompanied by a reduction 
of the global protein levels of SMARCAD1 (Figure 3.2.7). This effect was subsequently 
studied in depth by a colleague in the lab in three cell lines (Ding et al., 2018). KAP1 
knockdown had an effect on SMARCAD1 at the RNA level, even when an exogenous 
SMARCAD1 construct under the chicken β actin promoter was employed (Ding et al., 
2018). The KAP1 knockdown could therefore not be confidently used to determine 
SMARCAD1 binding on chromatin and the sequence of binding events. Instead, the 
interaction between KAP1 and SMARCAD1 was disrupted. 
 
Figure 3.2.7: SMARCAD1 protein levels are reduced globally after 4 days of KAP1 
knockdown. 
Western blot of a 4d transient KAP1 knockdown in mESCs from global whole cell protein 
extracts. KAP1 knockdown is known to affect the pluripotency of mES cells (Cheng et al., 2014a), 
accordingly Nanog is seen reduced. SMARCAD1 protein levels are also affected, an effect 





The direct interaction of SMARCAD1 and KAP1 was mapped by colleagues in this 
laboratory to the RING B-box coiled-coil (RBCC) domain of KAP1 and to the proximal 
coupling of ubiquitin conjugation to ER degradation (CUE1) domain of SMARCAD1 
(Ding et al., 2018) (Figure 3.2.8a). Mutations in two key residues of the CUE1 domain 
abolish the interaction of SMARCAD1 and KAP1 in vitro and severely perturb it in vivo. 
A cell line was established in this laboratory containing the CUE1-mutant construct over 
a doxycycline-induced knockdown of endogenous SMARCAD1. The CUE1-mutant is 
expressed at the same level than a WT-construct in the cells (Figure 3.2.8b).  
 
Figure 3.2.8: SMARCAD1 is recruited to chromatin via its CUE1 domain. 
(a) Cartoon depicting the domains of SMARCAD1. (b) Left panel: ChIP-qPCR of a FLAG-
SMARCAD1 (WT) and a FLAG-SMARCAD1 CUE1 mutant (CUE1 mt) over different subcategories 
of single-copy genes bound by SMARCAD1 in E14 mES cells (Imprinted genes, Zfp-genes, Ezr, and 
Polrmt). Shown is the mean enrichment of two biological replicates (+/-SE) as percent input. Right 
panel: WT and CUE1 mt binding to different subcategories of ERVs (VL30: class I, IAP, Mier3 (IAP), 
Bglap3 (IAP) and ERVK10C: class II), and to LINE1 elements in E14 mES cells. An intergenic site 
is shown as negative control. Shown is the mean enrichment of three biological replicates (+/-SE). 
except for Mier3 (IAP), n=2. P values are from paired two-tailed Student’s t-test: *p < 0.05, 
**p < 0.01. The Western blot on top illustrates equal expression levels of the WT and mutant 
construct in mES cells, expressed over an inducible knockdown of SMARCAD1. 
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SMARCAD1 CUE1 mutant provided the opportunity to investigate whether 
SMARCAD1 binding to its target sites is dependent upon its interaction with KAP1 via 
the CUE1 domain. Consistent with this model it was observed that the SMARCAD1 
CUE1 domain is essential for tethering SMARCAD1 to the nucleus (Ding et al., 2018). 
The binding to chromatin of the mutant compared to a wild-type construct was severely 
reduced on both single-copy genes (Figure 3.2.8, left panel) as well as on repetitive 
elements, specifically different types of ERVs (Figure 3.2.8, right panel). This 
demonstrates that SMARCAD1 recruitment to chromatin is dependent on an intact CUE1 
domain and likely its interaction with KAP1. 
Collectively, the top SMARCAD1 binding sites are predominantly in heterochromatic 
regions, both facultative and constitutive. Many of these SMARCAD1 peaks are co-
enriched with KAP1 as shown by sequential ChIP on exemplary SMARCAD1 binding 
sites. The recruitment of SMARCAD1 to chromatin was investigated via a KAP1-
interaction mutant, since a KAP1 knockdown proved to result in a double SMARCAD1-
KAP1 knockdown, and it was determined that SMARCAD1 is indeed recruited to the 





3.3. SMARCAD1 remodelling is required for the association of 
repressive factors and histone modifications to class I and II ERVs 
SMARCAD1 binds to class I and II ERVs together with KAP1, exhibiting the highest 
enrichment on IAPs. Class I and II ERVs are also bound by H3K9me3, in this study as 
well as in other H3K9me3 published datasets (Bulut-Karslioglu et al., 2014). In addition, 
the interaction of SMARCAD1 and KAP1 is required for the binding of SMARCAD1, 
on both single-copy targets and repetitive regions. If the interaction is interrupted by the 
CUE1 mutation in SMARCAD1, it is no longer stably bound to the tested targets. 
 
3.3.1. KAP1 and the histone methyltransferase SETBD1 are reduced 
over class II ERVs upon the loss of SMARCAD1 
To address the function of SMARCAD1 on ERVs, a loss-of-function approach was taken. 
What effect does the loss of SMARCAD1 have on KAP1 association and other factors 
involved in the establishment of heterochromatin on these sites, specifically the histone 
methyltransferase SETDB1? This question was investigated in two different mES cell 
lines, female and male, and under two different conditions of knockdown, stable and 
transient. Hence, any effects observed are not cell line specific. Additionally, the transient 
knockdown will reveal immediate effects of SMARCAD1 removal which might have 
been compensated for in the stable knockdown.  
ChIP-qPCR experiments in the stable knockdown show that SMARCAD1 is necessary 
for the binding or stabilization of KAP1 on ERVs (Figure 3.3.1a, b). KAP1 binding is 
significantly reduced over IAP elements as depicted by the consensus primer (Figure 
3.3.1a) as well as on a specific IAP element investigated. Primers for different structural 
elements of IAPs highlight this decrease over the entire element (Figure 3.3.1b). Other 
class II ERVs were investigated, such as ERVK10C, show a slight but not significant 
reduction of KAP1. Class I ERV elements display SMARCAD1 binding, however KAP1 
is not affected upon its removal on these sites in the stable SMARCAD1 knockdown. 
Class III elements show very little to no SMARCAD1 binding and KAP1 is unchanged 
upon SMARCAD1 loss, similarly to what was observed on non-LTR retrotransposons 
such as LINEs. The transient SMARCAD1 knockdown is discussed in more detail in 
section 3.3.5, briefly; KAP1 is significantly reduced over ERVK10C elements and also 
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shows a slight but not significant reduction over VL30 elements not seen in the stable 
knockdown (Figure 3.3.8). 
KAP1 serves as a recruiting platform for several factors important for ERV control 
(Cheng et al., 2014b; Iyengar and Farnham, 2011; Jang et al., 2018; Rowe et al., 2010). 
Among them the histone methyltransferase SETDB1. In order to determine the place of 
SMARCAD1 in this sequence of binding events, SETDB1 binding over ERVs was 
investigated upon SMARCAD1 knockdown. The result is that SETDB1 is reduced over 
consensus and specific IAP sites and over the class II ERV element MusD/ETn, which 
displays no KAP1 reduction upon SMARCAD1 loss (Figure 3.3.1c). As seen with KAP1, 
SETDB1 is primarily decreased over the 5’UTR of IAP elements (Figure 3.3.1d). The 
global protein levels of KAP1 and SETDB1 are unchanged upon the knockdown of 
SMARCAD1 as shown earlier (Figure 3.1.9). 
Taken together, this implies SMARCAD1 is required for the association of KAP1 to class 
II ERVs and in the sequence of binding events it is recruited prior to SETDB1, since 
SETDB1 is reduced upon the loss of SMARCAD1. On IAP and ERVK10C elements both 
KAP1 and SETDB1 are affected, whereas on the class II element MusD/ETn, only 





Figure 3.3.1: The ERV regulators KAP1 and SETDB1 are reduced upon the loss of 
SMARCAD1 at class II ERVs. 
(a) ChIP-qPCR of SMARCAD1 and KAP1 binding over different ERV classes in control and 
stable SMARCAD1 knockdown mES cells (PGK12.1). Depicted is the mean enrichment of three 
biological replicates (+/-S.E.). An intergenic site is shown as negative control. Enrichment is 
shown in percent input. (b) ChIP-qPCR of SMARCAD1 and KAP1 binding over different 
structural elements of IAPs (as depicted in the cartoon on top) in control and stable SMARCAD1 
knockdown mES cells (PGK12.1). Depicted is the mean enrichment of three biological replicates 
(+/-S.E.).  P values are from paired two-tailed Student’s t-test: *p < 0.05, **p < 0.01, 
***p < 0.001 (c) representative ChIP-qPCR of two biological replicates showing SETDB1 
binding over different ERV classes upon stable knockdown of SMARCAD1 and control in 
mES cells (PGK12.1). Enrichment is shown in percent input (+/-S.E.). (d) SETDB1 binding over 
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different structural elements of IAP in control and stable SMARCAD1 knockdown mES cells 
(PGK12.1). Representative example of two biological replicates. Enrichment is shown in percent 
input (+/-S.E.).  
 
3.3.2. Repressive histone marks H3K9me3 and H4K20me3 are 
decreased in SMARCAD1 knockdown on class II ERVs 
SETDB1 association to chromatin is reduced upon the loss of SMARCAD1. It being the 
histone methyltransferase that catalyses H3K9me3, this modification was investigated 
next.  Upon the loss of SMARCAD1 the global protein levels of H3 and H3K9me3 are 
unaffected (Figure 3.1.9), as well as global levels of H4K20me3 as shown by colleagues 
repeatedly (Sachs et al., 2019). However, a significant reduction of H3K9me3 was 
observed over IAP elements, this effect was seen with consensus primers and over the 
span of the entire element (Figure 3.3.2a, b) and was particularly pronounced over 
specific IAP elements (Figure 3.3.2a). This was confirmed in a second mES cell line 
(Figure 3.3.9). The repressive histone mark H4K20me3 was similarly reduced in two 
different SMARCAD1 knockdown cell lines over IAP elements. Compared to H3K9me3 
the decrease of H4K20me3 on IAPs genome-wide is mild, on two specific IAPs however 
it is very pronounced (Figure 3.3.2c). H3K9me3 is also mildly, but not significantly, 
reduced over MuLV, ERVK10C, and MusD/ETn. The small effect on ERVK10C 
elements is not surprising since it is bound by SMARCAD1, and KAP1 is also mildly 
reduced. However, MuLV displays very little or no SMARCAD1 binding, and 
MusD/ETn exhibits a reduction of SETDB1 upon stable SMARCAD1 knockdown, but 
not KAP1. Overall, this suggests the reduced H3K9me3 is not always concomitant of 
reduced KAP1, but on certain elements a reduction of SMARCAD1 alone results in less 
H3K9me3, whereas on the majority of sites both SMARCAD1 and KAP1 play a role in 




Figure 3.3.2: The repressive histone marks H3K9me3 and H4K20me3 are decreased upon 
loss of SMARCAD1 over class II ERVs. 
(a) ChIP-qPCR of H3 and H3K9me3 binding over different ERV classes in control and stable 
SMARCAD1 knockdown mES cells (PGK12.1). Depicted is the mean enrichment of three 
biological replicates (+/-S.E.). An intergenic site is shown as negative control. Enrichment is 
shown in percent input. (b) ChIP-qPCR of H3 and H3K9me3 binding over different structural 
elements of IAPs (as depicted in the cartoon on top) in control and stable SMARCAD1 
knockdown mES cells (PGK12.1). Depicted is the mean enrichment of three biological replicates 
(+/-S.E.).  P values are from paired two-tailed Student’s t-test: *p < 0.05, **p < 0.01, 
***p < 0.001. (c) ChIP-qPCR showing H4K20me3 binding over different ERV classes in two 
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different cell lines, the left panel depicts a stable SMARCAD1 knockdown and the right a 
transient knockdown. Enrichment is shown as fold binding over H3 (+/-S.E.).  
 
A comparable reduction of KAP1 and H3K9me3 is observed upon the transient removal 
of SMARCAD1 (Figure 3.3.8 and Figure 3.3.9). KAP1 is significantly reduced over IAP 
elements and over ERVK10C. In contrast to the stable knockdown, it is additionally 
reduced over the class I ERV VL30, yet not significantly, perhaps suggesting a redundant 
mechanism of regulation in the stable knockdown that does not initiate quickly enough 
in the transient knockdown (Figure 3.3.8). H3K9me3 was also investigated after 2 days 
of SMARCAD1 knockdown, however almost no H3K9me3 reduction was observed at 
this time point (data not shown) likely because it is passively lost throughout cell 
divisions. After 4 days of SMARCAD1 loss the effects on H3K9me3 association were 
particularly noticeable on three specific IAP elements but also on ERVK10C and 
importantly, H3K9me3 was recovered upon introduction of exogenous SMARCAD1 
(Figure 3.3.9) 
 
3.3.3. SMARCAD1 is required to retain the histone variant H3.3 
over class I and II ERVs  
The histone variant H3.3 has generally been linked to regions of high nucleosome 
turnover and has been associated with gene activation (Ahmad and Henikoff, 2002; 
Goldberg et al., 2010). It has however, also been shown that this variant localizes to 
facultative and constitutive heterochromatin and is enriched on repetitive regions, 
particularly class I and II ERVs, together with H3K9me3 and SETDB1 (Elsasser et al., 
2015). Loss of H3.3 resulted in decreased H3K9me3 over ERVs and a moderate 
deregulation of IAPs (Elsasser et al., 2015).  
Thus, the presence of this histone variant was investigated on ERVs upon the loss of 
SMARCAD1. Notably, the loss of SMARCAD1 has no impact on the global protein 
levels of H3.3 Figure 3.3.3a). Nevertheless, locally on chromatin, stable association of 
H3.3 is affected in both stable and transient SMARCAD1 knockdown (PGK12,1 and E14 
cells, respectively, (Figure 3.3.3b). The effect is most predominant on IAP elements, 
genome-wide (consensus IAP primer) as well as on specific IAP elements (within the 
Bglap3, Mier3 and Zfp575 genes). H3.3 binding is also affected on ERVK10C, another 
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ERV class II element, and over the class I element VL30 in the transient SMARCAD1 
knockdown (E14 cells) as seen for KAP1. The role of ATRX in the regulation of ERVs 
has been debated extensively (He et al., 2015; Hoelper et al., 2017; Sadic et al., 2015). In 
this project, ATRX was not found enriched on IAP elements while it was found bound at 
high levels to telomeres in the same experiment (Figure 3.3.3c). The possibility remains 
that this is cell line specific.  
 
Figure 3.3.3: The histone variant H3.3 is reduced over ERVs upon the loss of SMARCAD1. 
(a) Western blot of stable SMARCAD1 knockdown in PGK12.1 mES cells showing H3.3 is not 
globally affected. Lamin B1 and H3 are shown as loading controls. (b) ChIP-qPCR depicting 
H3.3 binding (lower panels) with H3 ChIP-qPCR as a negative control (upper panels) in a 4-day 
transient SMARCAD1 knockdown (right panels, E14, n=2) and in the stable knockdown (left 
panels, PGK, n=2). Class I (VL30) and class II (IAP, ERVK10C) ERVs are depicted. An 
intergenic site is shown as negative control. Enrichment is shown as percent input (+/-S.E.). (c) 
ATRX does no bind the 5’UTR of IAP elements in PGK12.1 ES cells. ChIP-qPCR depicting 
ATRX over telomeric regions and IAP elements from the same experiment (n=1). Enrichment is 
shown as percent input (+/- SE) and IgG is depicted as a negative binding control. 
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3.3.4. The loss of SETDB1 has no effect on SMARCAD1 binding 
Whereas for LINE1 elements the histone methyltransferase G9a is required for 
H3K9me3, on ERVs SETDB1 is the enzyme that is necessary for H3K9me3 deposition 
and silencing. It is recruited after KAP1 and is crucial for further association of silencing 
factors, such as HP1, and final repressive histone tail methylation (Cheng et al., 2014b; 
Iyengar and Farnham, 2011; Maksakova et al., 2013; Matsui et al., 2010; Schultz et al., 
2002). Is SMARCAD1 binding affected by the loss of SETDB1 and subsequent reduction 
of H3K9me3 on chromatin?  
 
Figure 3.3.4: SMARCAD1 binding over ERVs is unaffected upon the loss of SETDB1. 
(a) Western blot showing a 4-day transient SETDB1 knockdown in E14 mES cells. Global 
SMARCAD1 expression is unaffected. Lamin B1 is shown as negative control. (b) representative 
ChIP-qPCR of two biological replicates of H3K9me3 over ERVS upon SETDB1 knockdown. 
LINE1 and an intergenic site are shown as negative controls. (c) representative ChIP-qPCRs of 
two biological replicates of KAP1 and SMARCAD1 over ERVs upon a 4-day SEDTDB1 
knockdown. LINE1 and an intergenic site are shown as negative controls. Enrichment is shown 
as percent input (+/-S.E.). 
 
A 4-day transient SETDB1 knockdown (Figure 3.3.4a) was established in E14 mouse ES 
cells which showed the expected reduction of H3K9me3 over class I and II ERVs while 
LINE1 remains unaffected (Figure 3.3.4b). The Western blot also illustrates that global 
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protein levels of SMARCAD1 are not decreased. As expected KAP1 binding over ERVs 
remains at the same levels seen in control, in accord with a sequence of binding events 
that placed KAP1 before SETDB1 (Rowe et al., 2010; Schultz et al., 2002) (Figure 
3.3.4c). Interestingly, SMARCAD1 binding is similarly unaffected upon SETDB1 
knockdown and the subsequent decrease of H3K9me3, placing it upstream of SETDB1 
and H3K9me3, together with KAP1 binding. 
 
3.3.5. Chromatin remodelling by SMARCAD1 is required for the 
control of ERVs 
SMARCAD1 is required for the stable association of KAP1 (Figure 3.3.1), SETDB1 
(Figure 3.3.1), and repressive histone modifications (Figure 3.3.2). Since SMARCAD1 
is an ATP-dependent remodeller this raised the question whether the catalytic activity of 
SMARCAD1 is required for the binding of repressive factors to ERVs.  
 
Figure 3.3.5: The SMARCAD1 constructs are expressed equally and KAP1 and SETDB1 
protein levels are unaffected. 
Western blot from total extracts depicting the stable expression of three different SMARCAD1 
constructs on top of a doxycycline-inducible SMARCAD1 knockdown in E14 mES cells. The 
original control cell line is shown and the inducible SMARCAD1 knockdown in the two lanes on 
the right. The constructs reintroduce SMARCAD1 expression. V5 illustrates the equal expression 
of the three constructs. KAP1 and SETDB1 are unaffected. Lamin B1 is shown as a loading 
control. Molecular weight markers are indicated.  
101 
 
Colleagues in the lab had established an inducible SMARCAD1 knockdown in E14 mES 
cells and cell lines which reconstituted this knockdown with either the WT SMARCAD1, 
an ATPase mutant or a CUE1 mutant. Before investigating the effect on the association 
of repressive factors, it was confirmed that the constructs are expressed at equal levels 
(Figure 3.3.5). Furthermore, KAP1 and SETDB1 are unaffected in all cell lines used 
(Figure 3.3.5). This was confirmed by multiple Western blots in studies carried out by 
colleagues in the lab. 
To address the question whether the catalytical activity of SMARCAD1 plays a role on 
ERVs, ChIP-seq was performed on the WT and ATPase mutant. Indeed, it was found that 
the mutant binds class I and II ERV elements at significantly lower levels than the WT, 
most notably IAP elements (Figure 3.3.6b, c) but also other ERV elements such as VL30 
and ERVK10C show significantly reduced binding in two ATPase mutants compared to 
the WT construct (Figure 3.3.6c). This is most clearly seen in the FLAG ChIP-qPCR 
(Figure 3.3.6c), where the two ATPase mutants bind at very similarly reduced levels, the 
binding is however not abolished entirely. For simultaneous ChIP (-seq & -qPCR) in a 
large number of cell lines it was ensured that chromatin shearing gave similar reliable 
size distributions in order to successfully compare binding across cell lines over multiple 





Figure 3.3.6: The SMARCAD1 ATPase mutant is not stably associated to chromatin on 
ERVs. 
(a) Gel electrophoresis depicting the size distribution of sheared chromatin. Loaded on the gel is 
chromatin from E14 mES cells; control, 4d SMARCAD1 knockdown, and three cell lines 
containing different SMARCAD1 constructs (WT, CUE1 mutant, and ATPase mutant). A DNA 
ladder is loaded on the 1st lane from the left and fragment size ranges from 300bp to 900bp 
approximately, in all five cell lines. (b) Box plot portraying FLAG-SMARCAD1 constructs (WT 
and ATPase mt) binding to IAP subcategories in a 2d transient SMARCAD1 knockdown. The 
control contains the SMARCAD1 knockdown and no FLAG-construct. Enrichment is depicted 
as log2 fold over input. (c) FLAG ChIP-qPCR showing average enrichment from three biological 
replicates in four different cell lines (+/- S.E.) with the exception of the 2nd ATPase mutant on 
LINE1 elements (n=2). SMARCAD1 knockdown is shown as a control. The SMARCAD1 WT 
construct is successfully bound to class I and II ERVs (VL30, IAP and ERVK10C, respectively) 
whereas the SMARCAD1 ATPase mutant in two different cell lines is not stably bound to the 
repetitive elements. An intergenic site is shown as a negative control for binding. P values are 




This reduced chromatin association of the FLAG-ATPase mutants is reflected in the 
overall binding of SMARCAD1. SMARCAD1 binding is reduced in its transient 
knockdown and reconstituted by the WT construct on ERVs. Albeit this reconstitution is 
not entirely complete in rare cases (Figure 3.3.7 IAP, and data not shown). The two 
ATPase mutants however do not reconstitute SMARCAD1 association, its binding is 
even slightly lower than in the transient knockdown (Figure 3.3.7). This could suggest 
that some endogenous protein is “blocked” from binding in the ATPase mutants, however 
the effect compared to the levels in the knockdown is quite mild, and would require 
further investigation.  
 
 
Figure 3.3.7: The catalytic mutant does not reconstitute SMARCAD1 binding over ERVs. 
SMARCAD1 ChIP-qPCR of three biological replicates in five different cell lines over class I and 
II ERVs. Mier3 and Bglap3 represent specific IAPs within the annotated genes. Average 
enrichment is depicted (+/- S.E.) with the exception of the IAP within Bglap3, which was done 
in two biological replicates and the 2nd ATPase mutant, which was also done twice on all sites 
shown and accordingly has no p-value. Expected levels of SMARCAD1 association are seen in 
the ES cell line, and reduced upon SMARCAD1 knockdown. SMARCAD1 association to its 
binding sites is restored by the WT construct but not by the two different ATPase mutants. P 
values are from paired two-tailed Student’s t-test: *p < 0.05, **p < 0.01. 
 
How are the other ERV regulators affected in the SMARCAD1 mutants? KAP1 and 
H3K9me3 were investigated to address this question. KAP1 is no longer stably associated 
to class I and II ERVs in the ATPase mutant (Figure 3.3.8a, b). This is particularly 
pronounced on IAP elements, both with consensus and specific primers (Figure 3.3.8b) 
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and can also be seen in the box plot of KAP1 enrichment over IAPs from the ChIP-seq 
(Figure 3.3.8a). In contrast KAP1 binding is reconstituted when a WT SMARCAD1 
construct is introduced in a cell line with a transient SMARCAD1 knockdown, clearly 
showing that the reduced KAP1 in the SMARCAD1 knockdown is a direct consequence 
of the loss of remodelling on the investigated sites. The ATPase mutants, on the other 
hand, do not reconstitute KAP1 binding and show even less KAP1 binding than seen in 
the SMARCAD1 knockdown. Interestingly, in the CUE1 mutant KAP1 binding levels 
are reliably reconstituted to initial levels, suggesting that the interaction of KAP1 and 
SMARCAD1 is not necessary for KAP1 association to chromatin, however the presence 
of a certain level of SMARCAD1 bound together with KAP1 appears to be necessary 
since in a near-complete SMARCAD1 knockdown, KAP1 is still reduced over their 








Figure 3.3.8: A catalytic SMARCAD1 mutant results in reduced KAP1 association. 
(a)  KAP1 binding over different IAP subcategories in a SMARCAD1 WT and a SMARCAD1 
ATPase mutant cell line depicting reduced KAP1 association in the mutant. Enrichment is shown 
as log2 fold over input. (b) KAP1 ChIP-qPCR in three biological replicates over class I (VL30) 
and II (IAP & ERVK10C) ERVs with Mier3 and Bglap3 representing specific IAPs within the 
annotated genes. KAP1 binding in five different cell lines was investigated; Control, transient 
SMARCAD1 knockdown and three cell lines with SMARCAD1 constructs expressed over the 
knockdown: WT, two ATPase mutants, and a CUE1 KAP1-interaction mutant. Average 
Enrichment is shown (+/- S.E.). P values are from paired two-tailed Student’s t-test: *p < 0.05, 
**p < 0.01. Bglap3 was performed in biological duplicates as was the 2nd ATPase mutant, 
accordingly no p-values were calculated. 
 
When it comes to H3K9me3, it is reduced after four days of transient SMARCAD1 
knockdown (Figure 3.3.9). H3K9me3 association to chromatin over class I and II ERVs 
is restored in the cell line containing the WT SMARCAD1 construct, again illustrating 
the direct effect of SMARCAD1. Silencing is however not restored in the ATPase mutant 
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and neither is H3K9me3 fully reconstituted in the CUE1 KAP1-interaction mutant, even 
though KAP1 binding is back to normal levels which likely implies that the loss of 
SMARCAD1 remodelling alone has an impact on ERV repression apart from its impact 
on KAP1 association to chromatin (Figure 3.3.9). 
 
 
Figure 3.3.9: H3K9me3 is not reconstituted by the SMARCAD1 ATPase and CUE1 mutant. 
ChIP-qPCR showing H3K9me3 association to specific IAP elements in control, 4-day 
SMARCAD1 knockdown and reconstitution with WT, ATPase and CUE1 mutants. Enrichment 
(+/-S.E.) is shown as fold binding over H3 from the average of two biological replicates. An 
intergenic site is shown as negative control. 
 
Taken together these data illustrate the role of SMARCAD1 in the formation of the 
repressive complex on retrotransposons, and specifically that it is its catalytic function as 
an ATP-dependent chromatin remodeller that is required for the stable assembly of KAP1 
and H3K9me3 over these sites. SMARCAD1 knockdown affects KAP1, SETDB1 
binding and the association of repressive histone marks and variants over ERVs. 
However, the effects are slightly different in cell lines with a stable SMARCAD1 
knockdown compared to inducible knockdowns. Over IAPs the effect is very consistent. 
When it comes to the type I ERV element VL30, it is interesting to note that in the stable 
knockdown KAP1 is not affected but in the transient knockdown of SMARCAD1 it is 
reduced. In stable clones, cells have a lot of time to react to the knockdown of a protein. 
Possibly the lack of KAP1 reduction in the stable clone reveals a redundant mechanism 
that has kicked in to “rescue” the repression of VL30. Another interesting observation is 
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that over MusD/ETn KAP1 binding is not reduced but SETDB1 and H3K9me3 are 
affected albeit not significantly. This might hint towards slightly different repressive 
mechanisms over different elements. Notably, H3K9me3 is not affected over ERVK10C 
in the SMARCAD1 knockdown. Overall, SMARCAD1 and KAP1 are both important for 
the repression of IAPs but might play slightly different roles over other elements.  
SMARCAD1 binding to chromatin is required for the successful heterochromatisation of 
its ERV targets and the remodelling activity of SMARCAD1 plays a role in this 
mechanism. Further H3K9me3 is not fully reconstituted in the KAP1 interaction mutant 
implying that KAP1 alone is not enough for the complete repression of these elements. 
This is supported by expression data from the Mermoud lab, which reveals the de-
repression of IAP and ERVK10C elements upon SMARCAD1 knockdown. Additionally, 
the de-repression of IAP elements is rescued by the WT but not the ATPase mutant (Sachs 





3.4. SMARCAD1 binding sites in other cell types 
SMARCAD1 is expressed in MEFs and similar to ES cells it is localized throughout the 
nucleus and enriched on DAPI-dense loci which represent the pericentric heterochromatin 
in murine cells (Figure 3.4.1a). Moreover, SMARCAD1 is known to have functions in 
the maintenance of heterochromatin in somatic cells (Rowbotham et al., 2011), and its 
binding partner KAP1 has been shown to regulate ERVs in adult human cells (Tie et al., 
2018). It was assessed whether SMARCAD1 is bound to the same ERV subfamilies that 
are enriched in mES cells. However, the result is that SMARCAD1 is not bound to class 
I and II ERV target sites in MEFs (Figure 3.4.1b). At the same time, ChIP was performed 
with another antibody on a known target site to ensure that the quality of the chromatin 
and the ChIP worked in principle (Figure 3.4.1b).   
 
Figure 3.4.1: SMARCAD1 is not enriched on class I and II ERVs tested in MEFs. 
(a) Immunofluorescence staining of endogenous SMARCAD1 in mouse embryonic fibroblasts 
(MEFs), Control and SMARCAD1 KNOCK-OUT. (b) ChIP-qPCR showing SMARCAD1 
binding on class I and II ERVs, bound by SMARCAD1 in mES cells, in mouse embryonic 
fibroblasts. TFIIIC is shown as a positive control for enrichment on a tRNA gene and IgG is a 
negative binding control. Enrichment is shown as percent input (+/-S.E.) 
 
To continue the investigation whether SMARCAD1 plays a role in the control of ERVs 
in adult tissues, SMARCAD1 binding was examined during early mES cell 
differentiation. A differentiation protocol for mES cells by removal of LIF (Leukaemia 
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Inhibitory Factor), which inhibits differentiation, was performed to test whether 
SMARCAD1 still binds to chromatin.  
 
Figure 3.4.2: A five-day differentiation timecourse in female ES cells results in the expected 
decreased expression of pluripotency markers, SMARCAD1 and the increase of the ncRNA 
Xist. 
Protein (a) and RNA levels (b) of indicated factors were examined during a 5-day differentiation 
timecourse. (a) Western blot showing the reduction of the pluripotency marker Oct4 after 5 days 
(d5) in two separate mES cell differentiation experiments. SMARCAD1 is also shown slightly 
reduced during differentiation. Lamin B1 is shown as a loading control. (b) Relative RNA 
expression levels by qPCR of the pluripotency marker Rex1 as well as SMARCAD1. Xist is also 
portrayed in its expected upregulation during female mES cell differentiation. RNA expression 




A time course of differentiation was established and to control for successful 
differentiation the following markers were assessed: pluripotency markers Oct4 and Rex1 
(Figure 3.4.2). These markers are expected to decrease upon the exit of pluripotency. 
Another marker for differentiation is the upregulation of the ncRNA Xist, responsible for 
X inactivation in female ES cells during differentiation, which was also included in the 
controls (Figure 3.4.2). Pluripotency markers are down both on protein and RNA level 
(Figure 3.4.2a, b). SMARCAD1 itself is also downregulated (Figure 3.4.2b) in 
accordance with the previous observation by Jacqueline Mermoud that it is generally 
expressed at lower levels in somatic cells (Sachs et al., 2019; Xiao et al., 2017). The 
ncRNA Xist is upregulated in accordance with the onset of X inactivation expected during 
the differentiation of female ES cells (Figure 3.4.2b). It was possible to conclude that 5 
days of LIF depletion resulted in sufficiently differentiated cells.  
To address the question whether SMARCAD1 binds its targets in differentiated mES 
cells, chromatin was collected on day 5 of differentiation. In contrast to MEFs, 
SMARCAD1 is still bound to class II ERV elements in differentiated mES cells. (Figure 
3.4.3a). Additionally, SMARCAD1 is bound to the major and minor satellites of 
pericentric heterochromatin and to telomeres, albeit on satellites the enrichment is minor. 
Similarly, SMARCAD1 binding is maintained on the two regulatory promoters of Xist 




Figure 3.4.3: SMARCAD1 is enriched on its mES cell-specific binding sites after 5 days of 
ESC differentiation. 
(a) ChIP-qPCR of SMARCAD1 bound to IAP and ERVK10C elements in PGK12.1 control and 
knockdown cells on d0 and d5 of differentiation. Enrichment is shown as percent input (+/-S.E., 
n=2). (b) ChIP-qPCR of SMARCAD1 and KAP1 bound to major and minor satellites, and 
telomeres after 5 days of ESC differentiation in PGK12.1 control and SMARCAD1 knockdown 
cells. Enrichment is shown as percent input (+/-S.E., n=2). See Figure 3.2.2 for levels of 
SMARCAD1 enrichment on these sites at d0. (c) ChIP-qPCR of SMARCAD1 binding to the two 
promoters (P1, P2) of the ncRNA Xist in PGK12.1 control and knockdown cells on d0 and d5 of 
differentiation. Enrichment is shown as fold binding over IgG (+/-S.E., n=2). 
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It has recently been shown that KAP1 plays a role in silencing ERVs in an adult cell line 
(Ecco et al., 2016; Tie et al., 2018). During the course of this present study, it was 
hypothesized that the role of SMARCAD1 on ERVs might not be restricted to ES cells. 
No SMARCAD1 binding was detected on ERVs in mouse embryonic fibroblasts (MEFs) 
however SMARCAD1 binding on ERVs was also not lost after five days of ES cell 
differentiation. This implies SMARCAD1 is still bound to its targets upon the reduction 
of the pluripotency markers REX1 and OCT4. Importantly, the Smarcad1 gene is bound 
by NANOG, OCT4 and SOX2 (Efroni et al., 2008; Loh et al., 2006). SMARCAD1 
protein levels are globally reduced after 5 days of differentiation (Figure 3.4.2a) but this 
reduction is not seen on chromatin at this point (Figure 3.4.3).  
ERVs are bound and regulated in a tissue-specific manner and SMARCAD1 might play 
role in ERV regulation in other adult cell lines, such as KAP1, since the ERV family 
bound by KAP1 in somatic cells is a subcategory of ERVK elements not investigated in 
this study (Ecco et al., 2016; Tie et al., 2018). Further studies would clarify whether 








The results of this thesis revealed a role of SMARCAD1 in the establishment of silent 
chromatin on ERVs in ES cells. SMARCAD1 and KAP1 co-occupy the investigated 
binding sites and SMARCAD1 is recruited to chromatin by its interaction with KAP1, 
but in turn also stabilizes the association of KAP1 with chromatin. These interactions lead 
to the recruitment of SETDB1 and the establishment of the repressive histone 
modifications H3K9me3 and H4K20me3 (Figure 4.1). The presence of the histone variant 
H3.3 was confirmed within ERV elements and is found reduced upon the loss of 
SMARCAD1. The role of H3.3 has previously been investigated in ERV silencing and 
has been debated since (Elsasser et al., 2015) – discussed in 4.2.  
 
Figure 4.1: Model of the SMARCAD1-KAP1-SETDB1 silencing pathway. 
The repressive factors are localized to the chromatin by KRAB-ZFPs where SMARCAD1 and 
KAP1 stabilize each other and are required for the association of further silencing factors and the 
establishment of repressive histone modifications. For this function the chromatin remodelling of 
SMARCAD1 is essential. 
 
The catalytic activity of SMARCAD1 is necessary for stable KAP1 binding, whereas the 
interaction with SMARCAD1 is not, as seen in the CUE1 mutant. This implies that the 
presence of SMARCAD1 plays a role in the stabilization of KAP1 on chromatin, whereas 
in an almost complete knockdown of SMARCAD1 KAP1 is no longer bound at full levels 
to its binding sites. In the CUE1 mutant, H3K9me3 is not restored to WT levels, 
illustrating that KAP1 alone is not enough to fully repress transposable elements. This is 
reflected in the de-repression of ERVs in this instance observed by expression analysis 
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from the Mermoud lab and hence, SMARCAD1 and KAP1 are both necessary for the full 
repression of ERVs. KAP1 and H3K9me3 are equally not fully restored in the 
SMARCAD1 ATPase mutant (as is ERV repression in transcriptome data from the 
Mermoud lab), illustrating that it is indeed the catalytic activity of SMARCAD1 that plays 
a role in heterochromatin establishment on these sites (Figure 4.1).   
 
4.1. Targeting remodellers to chromatin  
ATP-dependent chromatin remodellers are generally recruited to chromatin by histone 
modifications or by co-factors. They often contain domains that bind histone 
modifications, such as bromo- and chromodomains, and a combination of histone 
modifications is generally involved in the recruitment. (Clapier and Cairns, 2009; Clapier 
et al., 2017b; Flaus and Owen-Hughes, 2011; Hota and Bruneau, 2016; Muller and Leutz, 
2001). SWI/SNF proteins are usually targeted by accessory proteins which modulate their 
activity, and integrate chromatin remodelling into cellular pathways (Hota and Bruneau, 
2016).  
SMARCAD1 does not have a DNA binding domain nor does it have a known domain 
that binds histone modifications. One candidate are  CUE motifs known to bind mono- 
and polyubiquitin (Hurley et al., 2006), hence a role of these domains in recognizing 
ubiquitylated histones has been debated (Byeon et al., 2013; Densham et al., 2016). 
However, a preference for ubiquitylated histones over unmodified histones has not been 
confirmed so far (Awad et al., 2010; Densham and Morris, 2017). The Mermoud lab has 
shown that SMARCAD1 directly interacts with recombinant non-ubiquitylated KAP1 via 
its CUE1 domain. Further, there is no competition in KAP1-CUE1 binding experiments 
upon the addition of ubiquitin (Ding et al., 2018). Hence, this is a novel interaction mode 
for CUE domains. This study has shown that SMARCAD1 binding to KAP1 targets 
requires an intact CUE1 domain. We infer that SMARCAD1 is recruited to or stabilised 
om chromatin by its interaction with KAP1. This is a major mechanism of targeting and 
relevant for the silencing of ERV elements. Open questions concern whether alternative 
mechanisms exist to target SMARCAD1 to chromatin. 
The ChIP-seq approach has demonstrated that SMARCAD1 and KAP1 share many 
common target sites and it is likely that the recruitment and stabilization of SMARCAD1-
KAP1 genome-wide involves the interaction with KAP1 via the CUE1 domain given that 
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the SMARCAD1 CUE1 domain is essential for tethering SMARCAD1 to the nucleus 
(Ding et al., 2018). This does not rule out other mechanisms of recruitment, perhaps on 
sites not shared with KAP1. Based on manual inspection of the binding sites, 
SMARCAD1 sites unbound by KAP1 appear to be the exception, but a thorough 
bioinformatic analysis is likely to give interesting candidates. One such example are the 
promoters of Xist. KAP1 binding has not been reported on Xist in published ChIP-seq 
(Elsasser et al., 2015) and hence SMARCAD1 recruitment might involve distinct 
mechanisms which possibly also play a role elsewhere in the genome. One different 
mechanism has been suggested by Xiao et al. who reported that SMARCAD1 
preferentially associates with H3 arginine 26 citrullination in vitro and is colocalized with 
this modification genome-wide (Xiao et al., 2017).  
Histone modifications other than ubiquitin could also play a role in recruiting 
SMARCAD1 to chromatin. In the case of H3K9me3 this present study has demonstrated 
that SMARCAD1 binding to chromatin on ERVs is not reduced upon H3K9me3 
reduction and this modification does not play a role in stabilizing SMARCAD1 on ERVs. 
Interestingly, Xiao et al. have shown that H3S28 phosphorylation inhibits SMARCAD1 
binding in vitro. It has been suggested that phosphorylation of a given site might result in 
the dissociation of a reader of lysine methylation on an adjacent residue as part of a 
“pospho/methyl switch” (Fischle et al., 2003). Indeed, phosphorylation of H3S28 upon 
stress resulted in displacement of PcG proteins from a subset of their targets (Gehani et 
al., 2010). Considering that SMARCAD1 binds many other targets outside of constitutive 
heterochromatin, the next step would be to investigate whether there are stress-regulated 
genes or elements among them, and if phosphorylation and SMARCAD1 displacement 
is induced upon stress on these sites. 
 
4.2. The role of chromatin remodelling by SMARCAD1 in the 
repression of ERVs 
This study has shown that the ATPase mutant of SMARCAD1 does not reconstitute the 
binding of repressive factors on ERVs implying the catalytic activity is required for the 
assembly of the silencing complex of KAP1-SETDB1-H3K9me3. The Mermoud lab has 
shown that SMARCAD1-bound ERVs are indeed upregulated upon the transient 
knockdown of SMARCAD1 and the repression is only restored partially with the ATPase 
mutant, while it is restored with the WT. So, what is SMARCAD1 doing on these sites 
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that requires its catalytic activity? In budding yeast, the SMARCAD1 homolog Fun30 
performs histone dimer exchange and nucleosome sliding (Awad et al., 2010; Byeon et 
al., 2013). In fission yeast, Fft3 is localized to LTRs residing within the transition zone 
between euchromatin and silent domains. In its absence nucleosome occupancy is 
decreased, as shown by Mnase-seq (Steglich et al., 2015; Stralfors et al., 2011). In mES 
cells, H3 is unaffected upon the loss of SMARCAD1 on all sites investigated by ChIP in 
this study. However, ChIP would likely only detect large-scale nucleosome eviction and 
nucleosome sliding not at all. To answer these questions, it would be quite interesting to 
perform nucleosome remodelling assays in vitro to determine what exactly SMARCAD1 
remodels. In vivo one would perform ATAC-seq or MNase-seq in the SMARCAD1 
ATPase mutant to investigate nucleosome occupancy over ERVs to determine the 
mechanistic nature of ERV de-repression upon the loss of remodelling. 
Are there other examples of ATP-dependent chromatin remodellers that play a role in the 
control of ERVs? One example is the remodeller Chd5 which plays a role in the 
occupancy of canonical H3.1/2 within MERVL elements and is involved in its regulation 
(Hayashi et al., 2016). Regarding the H3.3 data revealed in this present study, a more 
interesting candidate is the remodeller ATRX (alpha-thalassemia/mental retardation 
syndrome X-linked) which is known to deposit H3.3 within telomeres together with the 
chaperone DAXX (Wong et al., 2010). The data on ERVs is somewhat inconclusive so 
far, as it has been shown that ATRX binds a specific sequence within IAPs and promotes 
heterochromatin formation at retrotransposons (Sadic et al., 2015), it was further found 
that an ATRX knockdown upregulates the IAP1 subclass in ES cells (He et al., 2015). A 
third study, however, not only finds no effect of ATRX on the silencing of ERVs but also 
shows that there are indeed two distinct DAXX complexes, ATRX-DAXX and DAXX-
SETDB1-KAP1-HDAC1, with the latter playing a role in the repression of ERVs and this 
is achieved with the H3.3-dependent stabilisation of DAXX. An H3.3 mutant in their 
study could still be integrated into chromatin but no longer interacted with DAXX and in 
this context ERVs were still upregulated (Hoelper et al., 2017).   
In this present study, H3.3 is reduced within ERVs upon the knockdown of SMARCAD1 
but this has not been tested in the presence of the ATPase mutant, hence it cannot be 
concluded that it is the catalytic activity of SMARCAD1 affecting it on these sites. It 
could be speculated that remodelling by SMARCAD1 is involved in H3.3 deposition, 
possibly in consonance with DAXX instead of ATRX. This would suggest ATRX does 
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indeed not play a role on these sites as Hoelper et al postulated. The Mermoud lab found 
DAXX in mass spectrometry proteomic data of the SMARCAD1 ATPase mutant, albeit 
at rather low amounts (data not published), and KAP1 associates with DAXX (Elsasser 
et al., 2015). This could be tested by performing ChIP against H3.3 and H3.1/2 
simultaneously. Opposing this, is the fact that Hoelper et al found that H3.3 is not required 
within chromatin for the repression of ERVs. They do speculate that DAXX may serve 
as a bridging factor between the transcriptional repressing activities of HDACs and the 
H3K9me3 directed activity of the SETDB1-KAP1 proteins, so maybe it would be worth 
to investigate the effect SMARCAD1 has on DAXX directly. This present study has not 
found ATRX on IAP elements whereas in the same experiment ATRX was found highly 
enriched on telomeres, which would support the conclusion that ATRX does not play a 
major role on IAPs in the investigated cell line.   
The role of H3.3 on ERVs is however also somewhat elusive. Elsässer et al. demonstrated 
that H3.3 is enriched at ERVs, deposited there by ATRX-DAXX, and in a H3.3 knock-
out cell-line ERVs are derepressed which leads to increased retrotransposition. This 
conclusion has been challenged by Wolf et al., who re-analysed the published data. They 
confirmed the presence of H3.3 within ERVs but could not confirm the increased 
retrotransposition and found only mild ERV upregulation genome-wide upon the loss of 
H3.3 (Wolf et al., 2017). In their reply, Elsässer et al. explain the difference in the data 
analysis employed, and confirm that albeit the effect on ERV repression of an H3.3 
knock-out is not as drastic as what is observed upon the loss of SETDB1, it is still 
significant and even a subtle difference in ERV expression could be biologically 
important. They do however withdraw their conclusion about increased retrotransposition 
upon the loss of H3.3, but maintain that H3.3 plays an unexpected role in ERV silencing 
(Elsässer et al., 2017). 
This present study cannot state whether H3.3 plays a role in the regulation of ERVs. 
However, H3.3 is reduced upon the loss of SMARCAD1 and combined with the recent 
paper that showed no ATRX on ERVs it would be interesting to investigate the presence 
of H3.3 in the SMARCAD1 ATPase mutant to determine if SMARCAD1 plays a role in 




4.3. The repression ERVs by SMARCAD1 and the impact on gene 
regulation 
Apart from examining the exact mechanism of ATP-dependent chromatin remodelling by 
SMARCAD1 on ERVs, there are many other questions to be explored. Colleagues in the 
Mermoud lab have shown that ERVs are derepressed upon the transient loss of 
SMARCAD1, and more importantly so are nearby genes. This phenotype is not fully 
rescued by the ATPase mutant nor by the CUE mutant of SMARCAD1 (Sachs et al., 
2019), which is also reflected in the H3K9me3 binding data from this present study. This 
clearly illustrates that the silencing of retrotransposons stretches over to neighbouring 
genes and, upon the de-regulation of these elements, nearby genes are expressed. Hence, 
SMARCAD1 is necessary to maintain correct gene regulation in ES cells. Interestingly, 
the pluripotency of ES cells tracks very closely with the expression levels of 
retrotransposons (Gifford et al., 2013; Macfarlan et al., 2012). A comparison of Oct4 and 
Nanog binding sites in humans and mice has revealed a very low conservation but one 
fourth of these sites in both harbour ERV elements. Moreover, the expression of the 
majority of genes was affected by the depletion of Oct4 (Kunarso et al., 2010). This 
illustrates the plasticity of regulatory networks of ES cells as well as the role of ERVs 
within them. Reflecting this plasticity, ERVs additionally often function as tissue-specific 
promoters and alternative promoters. There are many examples of this phenomenon 
during development and in tissues such as the brain or the testis (Cohen et al., 2009).  
Taking this into account, there are several interesting questions about the role of 
SMARCAD1. As mentioned in the introduction and the results of this thesis, the loss of 
SMARCAD1 has a clear effect on the maintenance of pluripotency. While the Mermoud 
lab has found a direct link to the pluripotency network in proteomic interaction data, the 
role of SMARCAD1 on ERVs in this context merits additional exploration. SMARCAD1 
itself is bound by core pluripotency factors in the genome (Efroni et al., 2008; Loh et al., 
2006), reminiscent of an autoregulatory feedback loop. In accordance with these 
observations, it would be interesting to investigate the de-regulated genes close to 
SMARCAD1-bound ERVs by RNA-seq. Do they play a role in pluripotency? 
Additionally, using CRISPR technology it is now feasible to inactivate or delete specific 
LTRs to determine their effect upon the host transcriptome. Are these genes expressed in 
development and might therefore drive the exit of pluripotency upon their de-repression? 
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Possibly this would have to be investigated together with double knockdowns of other 
factors of ERV silencing to capture larger effects. 
From this present study, SMARCAD1 was not found bound to ERVs in MEFs but was 
also not lost after 5 days of differentiation. For KAP1 it is known that it plays a role in 
ERV silencing in several adult tissues, including the brain (Ecco et al., 2016; Fasching et 
al., 2015; Tie et al., 2018). Similar cell lines could be investigated for ERV silencing by 
SMARCAD1. In addition, the SMARCAD1 binding sites in ES cells could be 
investigated in several adult cell lines, with published DNAse I hypersensitivity data to 
correlate in what cell types they are now used as regulatory elements (together with data 
on active histone marks).  
Many questions remain about the extent to which retrotransposons can be repressed or 
activated in certain tissues or at particular developmental stages and which factors 
coordinate switches in these activation statuses. SMARCAD1 and its co-factors are 
potential candidates for these mechanisms. A specific and intriguing example of ERVs in 
gene regulation is their potential role in innate immunity. The emergence of ERVs 
coincides with the appearance of adaptive immunity in mammals, suggesting that the 
lympho-tropism of many retroviruses may have played a role in this process (Rowe and 
Trono, 2011). It has been shown that some ERV families act as interferon-induced 
enhancers for immune genes in humans and mice (Chuong et al., 2016). Interferons are 
pro-inflammatory signalling molecules that are released upon infection to promote the 
transcription of innate immunity factors. 
The interferon-induced enhancers contained within specific ERVs have dispersed in 
several mammalian genomes independently (Canadas et al., 2018; Chuong et al., 2016) 
and CRISPR-deletion of a subset in the human genome impaired the expression of 
adjacent interferon-induced genes, which revealed their involvement in the regulation of 
essential immune functions (Chuong et al., 2016). Instead of understanding the role of 
specific ERVs in innate immunity it would be worthwhile to investigate the role of their 
controlling factors. Indeed, recently it has been shown that the repression of ERVs by 
KAP1 in adult cells is conserved in human peripheral blood mononuclear cells and the 
loss of KAP1 leads to the activation of interferon-stimulated genes (Tie et al., 2018). 
Furthermore, SETDB1 has functions in immune evasion in certain cancer cells (Cuellar 
et al., 2017). Of course, ERVs in adult cell lines are generally silenced by DNA 
methylation, and not primarily by repressive histone modifications. Altogether, it would 
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be interesting to investigate the role of SMARCAD1 in this context, due to its link to 
DNA methylation (via NP95, discovered by the Mermoud lab) and its role in ERV 
silencing together with the KAP1-SETDB1 machinery. This has the potential to be 
employed to reactivate subsets of ERVs to harness their natural ability to trigger the innate 
immune response. 
 
4.4. Genome-wide binding sites of SMARCAD1 in mES cells 
SMARCAD1 binds many targets genome-wide other than ERVs and its exact role on 
these sites remains to be determined. Some interesting possibilities are discussed here. 
 
4.4.1. SMARCAD1 on pericentric heterochromatin  
This present study has demonstrated that SMARCAD1 binds satellites and telomeres via 
ChIP and its presence there is likely also dependent upon its interaction with KAP1. How 
KAP1 is recruited to these sites, however, remains a mystery. KAP1 is not affected upon 
the stable loss of SMARCAD1 on satellites and only mildly so, upon the transient loss of 
SMARCAD1 in ES cells. To further elucidate the role of SMARCAD1 one would have 
to look at the effect on histone modifications and whether its absence impacts DNA 
replication in ES cells. If the stabilization of SMARCAD1 is similarly dependent upon 
its interaction with KAP1 can be investigated in binding experiments with the CUE1-
mutant.  
 
4.4.2. SMARCAD1 on imprinting Control Regions (IRCs) 
This study has identified several SMARCAD1 peaks on the promoters of imprinted 
genes. Interestingly, it has previously been shown that a KRAB-ZFP (ZFP57) together 
with KAP1, binds the H3K9me3-bearing and DNA-methylated allele of Imprinting 
Control Regions (IRCs) (Quenneville et al., 2011; Strogantsev et al., 2015). KAP1 and 
ZFP57 associate with NP95 (or UHRF1), a protein known to be required for the 
maintenance of DNA methylation in ES cells (Avvakumov et al., 2008; Bostick et al., 
2007; Quenneville et al., 2011). The deletion of KAP1 results in the loss of 
heterochromatin marks on IRCs and the deletion of ZFP57 leads to ICR DNA 
demethylation (Quenneville et al., 2011). 
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The Mermoud lab has shown that SMARCAD1 interacts with NP95 in both mES and 
human cells and it has been confirmed in this laboratory with purified recombinant 
proteins that this is a direct interaction (unpublished data). Speculatively, SMARCAD1 
may link histone modifications established with the help of KAP1, to DNA methylation 
brought by NP95 and DNMT1. This would also be worth investigating on pericentric 
heterochromatin and ERVs, since all these elements require histone modifications during 
development, to protect them from the wave of DNA demethylation, and later in 
development acquire DNA methylation.   
 
4.4.3. SMARCAD1 on the 3’end of ZFP genes 
SMARCAD1 binds to the 3’end of a subset of KRAB-ZFP genes. The 3’end of ZFP genes 
is one of the first sites were a specific ZFP (ZFP274) was found responsible for the 
recruitment of KAP1, and they are also regions which co-localize with SETDB1 and 
H3K9me3 (Frietze et al., 2010). ZFPs recognize specific DNA sequences, so they are the 
factors that confer binding specificity to their co-factors. In order to attain a complete 
picture, the ChIP-seq overlap of hundreds of ZFPs would need to be investigated together 
with SMARCAD1 and other co-factors. To increase the complexity, the expression of 
ZFPs is highly tissue-specific, as they contribute to cell-specific gene regulation and make 
up a large network (Ecco et al., 2017; Emerson and Thomas, 2009). To speculate on the 
role of SMARCAD1 on the 3’end of ZFP genes: it is probable that remodelling plays a 
role in the establishment or maintenance of heterochromatin on these sites, perhaps to 






Chromatin remodellers slide, assemble, eject or edit nucleosomes influencing chromatin 
structure, DNA accessibility and transcriptional programmes. The SNF2-like remodeller 
SMARCAD1 is conserved from yeast to human cells and is highly expressed in mouse 
embryonic stem cells. Upon its loss cells lose their pluripotent phenotype but its function 
in ES cells is not known.  
In order to understand the role of SMARCAD1 in mouse embryonic stem cells a robust 
ChIP-seq protocol was developed for the tagged and endogenous protein in wild-type and 
knockdown cell lines. SMARCAD1 binding sites were found predominantly at intergenic 
sites genome-wide, and overlap with repressive histone modifications. Among the 
chromatin-bound proteins discovered enriched with SMARCAD1 binding sites is KAP1 
(KRAB-associated protein 1; Krüppel-associated box), a critical factor for the silencing 
of endogenous retroviral elements (ERVs) in mouse ES cell, the histone 
methyltransferase SETDB1 (SET Domain Bifurcated Histone Lysine Methyltransferase 
I), and the histone variant H3.3. Taken together, the discovered binding sites provide new 
understanding of SMARCAD1 function in ES cells and illustrate that in the open 
chromatin environment characteristic of the pluripotent state, SMARCAD1 is associated 
with transcriptional repression.  
An unresolved issue is how SMARCAD1 associates with its binding sites without a 
DNA-binding domain and no known domains for recruitment by histone modifications. 
Candidate SMARCAD1 targets were investigated and it was discovered that recruitment 
is dependent on the interaction with KAP1 via the CUE1 (Coupling of Ubiquitin 
conjugation to ER degradation) domain of SMARCAD1. Sequential ChIP experiments 
revealed that KAP1 and SMARCAD1 are co-enriched on their shared targets. 
Among the discovered binding sites of the remodeller SMARCAD1 are endogenous 
retroviral elements (ERVs) an abundant type of transposable element derived from viral 
integrations in the germline. ERV expression is tightly controlled by repressive factors as 
they pose a threat for genome stability. A series of knockdowns and ChIP-qPCR 
experiments was performed to understand the cooperation and underlying mechanisms of 
how these factors shape and control ERV heterochromatin. SMARCAD1 was identified 
as a crucial component; it is required for the association of the KAP1-SETDB1 silencing 
machinery over class I and II ERVs, and consequently the maintenance of the histone 
modifications H3K9me3 and H4K20me3. The histone variant H3.3 has a controversial 
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role in ERV control and is similarly reduced upon the loss of SMARCAD1, suggesting 
SMARCAD1 may be involved in the turn-over of this variant.  
In summary, heterochromatin organisation is perturbed when SMARCAD1 is not present 
at ERVs. The presence of H3K9me3 on the other hand is not necessary for SMARCAD1 
binding as shown in a SETDB1 knock-down. The assembly of KAP1 and H3K9me3 is 
rescued by the ectopic expression of wild-type SMARCAD1 but not by an ATPase 
mutant. Hence, it is the catalytic activity of SMARCAD1 and chromatin remodelling that 
is required for the silencing of ERVs. The KAP1 interaction mutant had no effect on the 
association of KAP1 itself but could similarly not restore H3K9me3 emphasizing that 
SMARCAD1 is required for successful heterochromatin formation on ERVs and 









Chromatin-Remodeller können Nukleosomen verschieben, zusammenfügen, ausstoßen 
oder diese restrukturieren, wobei sie die Chromatinstruktur, die Zugänglichkeit der 
DNA und die Transkriptionsprogramme der Zelle beeinflussen. Der SNF2-like 
Remodeller SMARCAD1 ist von Hefe bis zu menschlichen Zellen konserviert und wird 
in embryonalen Stammzellen (ES-Zellen) von Mäusen stark exprimiert. Bei seinem 
Verlust verlieren Zellen ihren pluripotenten Phänotyp, allerdings ist die Funktion von 
SMARCAD1 in Stammzellen nicht bekannt.  
Um die Rolle von SMARCAD1 in embryonalen Stammzellen zu verstehen, wurde ein 
robustes ChIP-seq-Protokoll für das getaggte und endogene Protein in Wildtyp- und 
Knockdown-Zelllinien entwickelt. SMARCAD1-Bindungsstellen liegen überwiegend in 
intergenen Stellen genomweit und überlappen mit repressiven Histonmodifikationen. 
Unter den mit SMARCAD1-Bindungsstellen angereicherten Chromatin-gebundenen 
Proteinen befindet sich KAP1 (KRAB-associated protein 1; Krüppel-associated box), 
ein kritischer Faktor für die Stummschaltung endogener retroviraler Elemente (ERVs) 
in Maus-ES-Zellen, die Histonmethyltransferase SETDB1 (SET Domain Bifurcated 
Histone Lysine Methyltransferase I) und die Histonvariante H3.3. 
Zusammengenommen liefern die entdeckten Bindungsstellen ein neues Verständnis der 
SMARCAD1-Funktion in ES-Zellen und veranschaulichen, dass SMARCAD1 in der 
für den pluripotenten Zustand charakteristischen offenen Chromatin-Umgebung mit 
Transkriptionsrepression assoziiert ist.  
Ein ungelöstes Problem ist, wie SMARCAD1 ohne DNA-Bindungsdomäne und ohne 
bekannte Domänen für die Rekrutierung durch Histonmodifikationen mit seinen 
Bindungsstellen assoziiert. Verschiedene Kategorien von SMARCAD1 Bindungsstellen 
wurden untersucht und es wurde entdeckt, dass die Rekrutierung von der Interaktion mit 
KAP1 über die CUE1-Domäne (Coupling of Ubiquitin conjugation to ER degradation) 
von SMARCAD1 abhängt. Sequenzielle ChIP-Experimente zeigten, dass KAP1 und 
SMARCAD1 an ihren gemeinsamen Bindungsstellen zugleich angereichert sind. 
Unter den entdeckten Bindungsstellen des Remodellers SMARCAD1 befinden sich 
endogene retrovirale Elemente (ERVs), eine häufig vorkommende Art transponierbarer 
Elemente, die aus viralen Integrationen in der Keimbahn stammen. Die ERV-
Expression wird durch repressive Faktoren streng kontrolliert, da sie sonst eine 
Bedrohung für die Genomstabilität darstellen. Eine Reihe von Knockdown und ChIP-
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qPCR-Experimenten wurde durchgeführt, um zu verstehen, wie diese Faktoren ERV-
Heterochromatin formen. SMARCAD1 wurde als entscheidende Komponente 
identifiziert; es ist nötig für die Assoziation der repressiven Faktoren KAP1 und 
SETDB1 zu ERVs der Klassen I und II und folglich für die Erhaltung von den 
Histonmodifikationen H3K9me3 und H4K20me3. Die Histonvariante H3.3 spielt eine 
kontroverse Rolle bei der ERV-Kontrolle und wird beim Verlust von SMARCAD1 
reduziert, was darauf hindeutet, dass SMARCAD1 an dem Turnover dieser Variante 
beteiligt sein könnte. 
Zusammenfassend lässt sich sagen, dass die Heterochromatin-Organisation ist gestört, 
wenn SMARCAD1 nicht auf ERVs vorhanden ist. Das Vorhandensein von H3K9me3 
ist andererseits für die SMARCAD1-Bindung nicht erforderlich, wie in einem 
SETDB1-Knockdown gezeigt. Die Assemblierung von KAP1 und H3K9me3 wird 
durch die ektopische Expression von Wildtyp-SMARCAD1, jedoch nicht durch eine 
ATPase-Mutante gerettet. Daher sind es die katalytische Aktivität von SMARCAD1 
und das Chromatin-Remodelling, die für die Stummschaltung von ERVs erforderlich 
sind. Die KAP1-Interaktionsmutante hatte keinen Einfluss auf die Assoziation von 
KAP1 selbst, konnte jedoch H3K9me3 ebenfalls nicht wiederherstellen, was zeigt, dass 
SMARCAD1 für eine erfolgreiche Heterochromatinbildung auf ERVs erforderlich ist. 
Damit ist die Chromatin-Remodellierung als Schlüsselmechanismus der ERV-Kontrolle 
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